Probiotic spectra of lactic acid bacteria (LAB)

Critical Reviews in Food Science and Nutrition

Volumn 39, Issue 1, 1999, Pages 13-126

  Naidu, A S ^a   Bidlack, W R ^a   Clemens, R A ^b  

^a CALIFORNIA STATE POLYTECHNIC UNIVERSITY   (United States)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Clinical trials; Immunomodulation; Lactic acid bacteria (LAB); Prebiotics; Probio active compounds; Probiotics

Indexed keywords

BACTERIA (MICROORGANISMS);

BACTERIOCIN; PROBIOTIC AGENT;

ANIMAL; BIOSYNTHESIS; CLINICAL TRIAL; DIARRHEA; DIGESTIVE SYSTEM; FERMENTATION; FOOD CONTROL; GASTROINTESTINAL DISEASE; HUMAN; IMMUNE SYSTEM; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; REVIEW;

ANIMALS; BACTERIOCINS; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 2; DIARRHEA; DIGESTIVE SYSTEM; FERMENTATION; FOOD MICROBIOLOGY; GASTROINTESTINAL DISEASES; HUMANS; IMMUNE SYSTEM; LACTOBACILLUS; NEOPLASMS; PROBIOTICS;

EID: 0032603152     PISSN: 10408398     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408699991279187     Document Type: Article

References (490)

1. Lilley, D. M. and Stillwell, R. H., Probiotics: growth promoting factors produced by microorganisms, Science, 1965; 147: 747-748.
2. Parker, R. B., Probiotics, the other half of the antibiotic story, Animal Nutr. Hlth., 1974; 29: 4-8.
3. Fuller, R., Probiotics in man and animals, J. Appl. Bacteriol., 1989; 66: 365-378.
4. Lister, J., A further contribution to the natural history of bacteria and the germ theory of fermentative changes, Quart. J. Microsc. Sci., 1873; 13: 380-408.
5. Beijernick, M. W., Anhaufungsversuche mit Ureumbakterien. Ureumspaltung durch Urease and durch Katabolismus, Zentrabl. Bakteriol. Parasitenkd. Infektionskr. Hyg. II Abt, 1901; 7: 33-61.
6. Metchnikoff, E., The Prolongation of Life, Heinemann, London, 1907.
7. Tissier, H., Taxonomy and ecology of bifidobacteria, Bifidobacteria Microflora, 1905; 3: 11-28.
8. Fuller, R., Probiotic foods - current use and future developments, IFI NR., 1993; 3: 23-26.
9. Gerritse, K., Posno, M., Schellekens, M. M., Boersma, W. J., and Claassen, E., Oral administration of TNP-Lactobacillus conjugates in mice: a model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilli, Res. Microbiol., 1990; 141: 955-962.
10. McKay, L. L., Roles of plasmids in starter cultures, in Bacterial Starter Cultures for Foods, Gilliland, S. E., Ed., CRC Press Inc., Boca Raton, Florida, 1985, 159-174.
11. McKay, L., and Baldwin, K., Applications for biotechnology: present and future, FEMS Microbiol. Rev., 1990; 7(1-2): 3-14.
12. Gasson, M. J., Genetic transfer systems in lactic acid bacteria, Antonie van Leeuwenhoek, 1993; 49: 275-282.
13. De Vuyst, L. and Vandamme, E. J., Antimicrobial potential of lactic acid bacteria. In: Bacteriocins of lactic acid bacteria, De Vuyst, L. and Vandamme, E. J., Eds., Chapman and Hall, London, 1994, 91-142.
14. Moore, W. E. C. and Holdeman, L. V., Human fecal flora: the normal flora of 20 Japanese-Hawaiians, Appl. Microbiol., 1974; 27: 961.
15. Mital, B. K. and Garg, S. K., Anticarcinogenic, hypocholesterolemic, and antagonistic activities of Lactobacillus acidophilus, Critical Rev. Microbiol., 1995; 21(3): 174-214.
16. Mitsuoka, T., The human gastrointestinal tract. In: The Lactic acid bacteria, Wood, B. J. B., Ed., Elsevier Applied Science, New York, 1992, 69-114.
17. Benno, Y., Suzuki, K., Narisawa, K., Bruce, W. R., and Mitsuoka, T., Comparison of fecal microflora in rural Japanese and urban Canadians, Microbiol. Immunol., 1986; 30: 521-532.
18. Balmer, S. E., Hanvey, L. S., and Wharton, B. A., Diet and fecal flora in the newborn: nucleotides, Arch. Dis. Child., 1994; 70: 137-140.
19. Stark, P. L., and Lee, A., The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life, J. Med. Microbiol., 1982; 15: 189-203.
20. Clements, M. L., Levine, M. M., and Black, R. E., Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli, Antimicrob. Agents Chemother., 1981; 20: 104-108.
21. Saxelin, M., Elo, S., Salminen, S., and Vapaatalo, H., Dose response colonisation of faeces after oral administration of Lactobacillus casei strain GG, Microbial Ecol. Hlth. Dis., 1991; 6: 119-122.
22. Chauviere, G., Barbat, A., Fourniat, J., and Servin, A. L., Adhesion of lactobacillus on to the cultured human enterocyte-like cell lines Caco-2 and HT-29. Comparision between human and non-human strains, In: Les laits fermentes. Actualite de la recherche, John Libbey Eurotext Ltd., 1989, 287.
23. Conway, P., and Kjellberg, S., Protein-mediated adhesion of Lactobacillus fermentum strain 737 to mouse stomach squamous epithelium, J. Gen. Microbiol., 1989; 135: 1175-1186.
24. Brooker, B. F. and Fuller, R., Adhesion of lactobacilli to the chicken crop epithelium, J. Ultrastruct. Res., 1975; 52: 21-31.
25. Chan, R. C. Y., Reid, G., Irvin, R. T., Bruce, A. W., and Costerton, J. W., Competitive exclusion of uropathogens from human uroepithelial cells by lactobacillus whole cells and cell wall fragments, Infect. Immun., 1985; 47: 84-89.
26. Wadström, T., Andersson, K., Sydom, M., Axelsson, L., Lindgren S, and Gullmar, B., Surface properties of lactobacilli isolated from the small intestine of pigs, J. Appl. Bacteriol., 1987; 62: 513-520.
27. Henriksson, A., Szewzyk, R., and Conway, P. L., Characteristics of the adhesive determinants of Lactobacillus fermentum 104, Appl. Environ. Microbiol., 1991; 57: 499-502.
28. Schneitz, C., Nuotio, L., and Lounatma, K., Adhesion of Lactobacillus acidophilus to avian intestinal epithelial cells mediated by the crystalline bacterial cell surface layer (S-layer), J. Appl. Bacteriol., 1993; 74: 290-294.
29. Tannock, G. W., The microecology of Lactobacilli inhabiting the gastrointestinal tract. In: Advances in microbial ecology, Marshall, K. C., Ed., Plenum Press, New York, 1990, 147-171.
30. Elo, S., Saxelin, M., and Salminen, S., Attachment of Lactobacillus casei strain GG to human colon carcinoma cell line Caco-2: comparison with other dairy strains, Lett. Appl. Microbiol., 1991; 13: 154-156.
31. Bernet, M. F., Brassart, D., Neeser, J. R., and Servin, A. L., Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions, Appl. Environ. Microbiol., 1993; 59: 4121-4128.
32. Greene, J. D., and Klaenhammer, T. R., Factors involved in adherence of lactobacilli to human Caco-2 cells, Appl. Environ. Microbiol., 1994; 60: 4487-4494.
33. Zilliken, F., Rose, C. S., Braan, G. A., and Gyorgy, P., Preparation of alkyl-N-acetyl-A and B-O-glucosaminides and their macrobiological activity for L. bifidus, Arch. Biochem. Biophys., 1954; 48: 225.
34. Rasic, J. L. and Kurmann, J. A., Bifidobacteria and their role. In: Experientia supplementum, Vol. 39, Birkhauser Verlag, Basel, 1983.
35. Ashoor, S. H. and Monte, W. C., High performance liquid chromatographic determination of Bifidobacterium bifidum growth factors in human milk, J. Assoc. Off. Anal. Chem., 1983; 66: 135-139.
36. Petschow, B. W. and Talbott, R. D., Growth promotion of Bifidobacterium species by whey and casein fractions from human and bovine milk, J. Clin. Microbiol., 1991a; 28(2): 287-292.
37. Petschow, B. W. and Talbott, R. D., Response of Bifidobacterium species to growth promoters in human and cow milk, Pediatr. Res., 1991b: 29: 208-213.
38. Romond, M. B., Hamze, M., Romond, C., and Bourlioux, P., Host-bifidobacterium interactions in the axenic mouse: partial characterization of bifidogenic factors in the intestinal contents, Can. J. Microbiol., 1990; 36: 286-291.
39. Poch, M. and Bezkorovainy, A., Growth-enhancing supplements for various species of the genus Bifidobacterium, J. Dairy Sci., 1988; 71: 3214-3321.
40. Ishizaki, A., Natural rubber serum that contains a special growth promoter for Bifidobacterium, Biosci. Biotechnol. Biochem., 1995; 59: 1150-1151.
41. Kaneko, T., Mori, H., Iwata, M., and Meguro, S., Growth stimulator for bifidobacteria produced by Propionibacterium freudenreichii and several intestinal bacteria, J. Dairy Sci., 1994; 77: 393-404.
42. Mori, H., Sato, Y., Taketomo, N., Kamiyama, T., Yoshiyama, Y., Meguro, S., Sato, H., and Kaneko, T., Isolation and structural identification of bifidogenic growth stimulator produced by Propionibacterium freudenreichii, J. Dairy Sci., 1997; 80: 1959-1964.
43. Hara, H., Orita, N., Hatanao, S., Ichikawa, H., Hara, Y., Matsumoto, N., Kimura, Y., Terada, A., and Mitsuoka, T., Effect of tea polyphenols on fecal flora and fecal metabolic products of pigs, J. Vet. Med. Sci., 1995; 57(1): 45-49.
44. Topouzian, N., Joseph, B. J., and Bezkorovainy, A., Effect of various metals and calcium metabolism inhibitors on the growth of Bifidobacterium bifidum var. pennsylvanicus, J. Pediatr. Gastroenterol. Nutr., 1984; 3: 137-142.
45. Gibson, G. R. and Roberfroid, M. B., Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics, J. Nutr., 1995a; 125: 1401-1412.
46. Fuller, R. and Gibson, G. R., Modification of the intestinal microflora using probiotics and prebiotics, Scand. J. Gastroenterol. Suppl., 1997; 222: 28-31.
47. Roberfroid, M. B., Health benefits of non-digestible oligosaccharides, Adv. Exp. Med. Biol., 1997; 427: 211-219.
48. Gibson, G. R. and Wang, X., Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture, FEMS Microbiol. Lett., 1994; 118: 121-127.
49. Gibson, G. R., Beatty, E. R., Wang, X., and Cummings, J. H., Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin, Gastroenterology, 1995b; 108: 975-982.
50. Patterson, J. A., Orban, J. I., Sutton, A. L., and Richards, G. N., Selective enrichment of bifidobacteria in the intestinal tract of broilers by thermally produced ketoses and effect on broiler performance, Poult. Sci., 1997; 76: 497-500.
51. Bouhnik, Y., Flourie, B., D'Agay-Abensour, L., Pochart, P., Gramet, G., Durand, M., and Rambaud, J. C., Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in health humans, J. Nutr., 1997; 127(3): 444-448.
52. Salminen, S., and Salminen, E., Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection, Scand. J. Gastroenterol. Suppl., 1997; 222: 45-48.
53. Jaskari, J., Kontula, P., Siitonen, A., Jousimies-Somer, H., Mattila-Sandholm, T., and Poutanen, K., Oat beta-glucan and xylan hydrolysates as selective substrates for Bifidobacterium and Lactobacillus strains, Appl. Microbiol. Biotechnol., 1998; 49: 175-181.
54. Lambert, R., and Zilliken, F., Novel growth factor for Lactobacillus bifidus var. pennsylvanicus, Arch. Biochem. Biophys., 1965; 110: 544.
55. Jao, Y. C., Growth effect of N-acetylhexosamines on Lactobacillus bifidus variant pennsylvanicus, M.S. thesis, Ohio State Univ, Columbus, OH, 1974.
56. Jao, Y. C., Mikolajcik, E. M., and Hansen, P. M. T., Growth of Bifidobacterium bifidus var. pennsylvanicus in laboratory media supplemented with amino sugars and spent broth from Escherichia coli, J. Food Sci., 1978; 43: 1257.
57. Fleming, S. E. and Groot-Wassink, J. W. D., Preparation of high-fructose syrus from the tubers of the Jerusalem artichoke (Helianthus tuberosus), CRC Crit. Rev. Food Sci. Nutr., 1979; 12: 1.
58. Kawase, K., Suzuki, T., Kiyosawa, I., Okonogi, S., Kawashima, T., and Kuboyama, M., Effects of composition of infant formulas on the intestinal microflora of infants, Bifidobact. Microflora, 1983; 2: 25.
59. Hidaka, H., Hara, T., Eida, T., Okada, A., Shimaka, K., and Mitsuoka, T., Effect of fructo-oligosaccharides on human intestinal flora, RIKEN Intestinal Flora Symp., 1984; 4: 1 (in Japanese).
60. Mizota, T., Tamura, Y., Tomita, M., and Okonogi, S., Lactulose as a sugar with physiological significance, Int. Dairy Fed. Bull. Doc., 1987; 212.
61. Harju, M., Lactitol as a substrate for β-galactosidases. I. Literature review and methods. Milchwissenschaft., 1988; 43: 76.
62. Kunz, C. and Rudloff, S., Structural and functional aspects of oligosaccharides in human milk, Z. Ernahrungswiss, 1996; 35: 22-31.
63. Roberfroid, M. B., Van Loo, J. A., and Gibson, G. R., The bifidogenic nature of chicory inulin and its hydrolysis products, J. Nutr., 1998; 128(1): 11-19.
64. Gibson, G. R., Saavedra, J. M., Macfarlane, S., and Macfarlane, G. T., Probiotics and intestinal infections. In: Probiotics 2: Applications and practical aspects, Fuller, R., Ed., Chapman & Hall, New York, 1997, 10-39.
65. Saavedra, J. M., Microbes to fight microbes: a not so novel approach to controlling diarrheal disease, J. Pediatr. Gastroenterol. Nutr., 1995; 21(2): 125-129.
66. Havenaar, R., Brink, B., and Huis in't Veld, J. H. J., Selection of strains for probiotic use. In: Probiotics, the scientific basis, Fuller, R., Ed., Chapman and Hall, London, 1992, 209-224.
67. Sanders, M. E., Healthful attributes of bacteria in yogurt, Contemporary Nutr., vol. 18: pp. 1-2, General Mills, Minneapolis, MN, 1993.
68. Ingram, M., Ottoway, F. J. H., and Coppock, J. B. M., The preservative action of acid substances in food, Chem. Ind., 1956; 42: 1154-1165.
69. Lindgren, S. E. and Dobrogosz, W. J., Antagonistic activities of lactic acid bacteria in food and feed fermentations, FEMS Microbiol. Rev., 1990; 87: 149-164.
70. Baird-Parker, A. C., Organic acids, in Microbial ecology of foods, Silliker, J. H., Elliott, R. P., Baird-Parker, A. C., Bryan, F. L., Christian, J. H. B., Clark, D. S., Olson, J. C., and Roberts, T. R., Eds., Academic Press, New York, 1980, 126-135.
71. Kao, C. T., and Frazier, W. C., Effect of lactic acid bacteria on growth of Staphylococcus aureus, Appl. Microbiol., 1996; 14: 251-255.
72. Haines, W. C. and Harmon, L. G., Effect of selected lactic acid bacteria on growth of Staphylococcus aureus and production of enterotoxin, Appl. Microbiol., 1973; 25: 436-444.
73. Goepfert, J. M. and Hicks, R., Effect of volatile fatty acids on Salmonella typhimurium, J. Bacteriol., 1969; 97: 956-958.
74. Adams, M. R. and Hall, C. J., Growth inhibition of food borne pathogens by lactic and acetic acids and their mixtures., Int. J. Food Sci. Technol., 1988; 23: 287-292.
75. Wong, H. C. and Chen, Y. L., Effects of lactic acid bacteria and organic acids on growth and germination of Bacillus cereus, Appl. Environ. Microbiol., 1988; 54: 2179-2184.
76. Midolo, P. D., Lambert, J. R., Hull, R., Luo, F., and Grayson, M. L., In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria, J. Appl. Bacteriol., 1995; 79(4): 475-479.
77. Scardovi, V., Bifidobacterium, in Bergey's manual of systematic bacteriology, 9th Ed. Volume 2, Sneath, P. H., Mair, N. S., Sharpe, M. E., and Holt, J. G., Eds., Williams and Wilkins Publishers, Baltimore, MD, 1986, 1418.
78. Hidaka, H. and Eida, T., Roles of fructooligosaccharides for the improvements of intestinal flora and supression of production of putrid substances, Shokuhim-Kogyo, 1988; 31: 52.
79. Mitsuoka, T., Taxonomy and ecology of bifidobacteria, Bifidobact. Microflora, 1984; 3: 11.
80. Hidaka, H., Eida, T., Takizawa, T., Tokunaga, T., and Tashiro, Y., Effects of fructo-oligosaccharides on intestinal flora and human health, Bifidobacteria Microflora, 1986; 5: 37-50.
81. Mitsuoka, T., Recent trends in research on intestinal flora, Bifidobacteria Microflora, 1982; 1: 3-24.
82. Modler, H. W., McKellar, R. C., Goff, H. D., and Mackie, D. A., Using ice cream as a mechanism to incorporate bifidobacteria and fructooligosaccharides into the human diet, Cultured Dairy Prod. J., 1990b; August: 4-9.
83. Morris, J. G., Nature of oxygen toxicity in anaerobic microorganisms, In: Strategies of microbial life in extreme environments, Shilo, M., Ed., Verlag Chemi, Berlin, 1979, 149-162.
84. - in free radical damage to biological systems, Arch. Biochem. Biophys., 1980; 204: 13-29.
85. Dahl, T. A., Midden, W. R., and Hartman, P. E., Comparison of killing of Gram-negative and Gram-positive bacteria by pure singlet oxygen, J. Bacteriol., 1989; 171: 2188-2194.
86. Piard, J. C., and Desmazeaud, M., Inhibiting factors produced by lactic acid bacteria. II. Bacteriocins and other antibacterial substances, Lait, 1992; 71: 525-541.
87. Klebanoff, S. J., Clem, W. H., and Luebke, R. G., The peroxidase-thiocyanate-hydrogen peroxide antimicrobial system, Biochim. Biophys. Acta, 1966; 117(1): 63-72.
88. Dahiya, R. S. and Speck, M. L., Hydrogen peroxide formation by lactobacilli and its effect on Staphylococcus aureus, J. Dairy Sci., 1968; 51(10): 1068-1072.
89. Murphy, M. G. and Condon, S., Correlation of oxygen utilization and hydrogen peroxide accumulation with oxygen induced enzymes in Lactobacillus plantarum cultures, Arch. Microbiol., 1984; 138(1): 44-48.
90. Nunez de Kairuz, M. S., Olazabal, M. E., Oliver, G., Pesce de Ruiz Holgado, A. A., Massa, E., and Farias, R. N., Fatty acid dependent hydrogen peroxide production in Lactobacillus, Biochem. Biophys. Res. Commun., 1988; 152(1): 113-121.
91. Eschenbach, D. A., Davick, P. R., Williams, B. L., Klebanoff, S. L., Young-Smith, K., Critchlow, C. M., and Holmes, K. K., Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis, J. Clin. Microbiol., 1989; 27(2): 251-256.
92. Hillier, S., Krohn, M., Klebanoff, S., and Eschenbach, D., The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women, Obstet. Gynecol., 1992; 79(3): 369-373.
93. 2-producing lactobacilli, and bacterial vaginosis in pregnant women, Clin. Infect. Dis. (Suppl. 4), 1993; 16: S273-S281.
94. McGroarty, J. A., Tomeczek, L., Pond, D. G., Reid, G., and Bruce, A. W., Hydrogen peroxide production by Lactobacillus species: correlation with susceptibility to the spermicidal compound nonoxynol-9, J. Infect. Dis., 1992; 165(5): 1142-1144.
95. Hawes, S. E., Hillier, S. L., Benedetti, J., Stevens, S. E., Koutsky, L. A., WolnerHanssen, P., and Holmes, K. K., Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections, J. Infect Dis., 1996; 174(5): 1058-1063.
96. Klebanoff, S. J. and Coombs, R. W., Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus typel: possible role in heterosexual transmission, J. Exp. Med, 1991; 174(1): 289-292.
97. 2-generating lactobacilli, J. Infect. Dis., 1991; 164(1): 94-100.
98. 2-producing lactobacilli on Neisseria gonorrhoeae growth and catalase activity, J. Infect. Dis., 1994; 170(5): 1209-1215.
99. Fitzsimmons, N. and Berry, D. R., Inhibition of Candida albicans by Lactobacillus acidophilus: evidence for the involvement of a peroxidase system, Microbios, 1994; 80(323): 125-133.
100. Nes, I. F., Diep, D. B., Havarstein, L. S., Bruberg, M. B., Eijsink, V., and Holo, H., Biosynthesis of bacteriocins in lactic acid bacteria, Antonie Van Leewenhoek, 1996; 70(2-4): 113-128.
101. Holo, H., Nulssen, O., and Nes, I. F., Lactococcin A, a new bacteriocin from Lactococcus lactis subsp. cremoris: isolation and characterization of the protein and its gene, J. Bacteriol., 1991; 173: 3879-3887.
102. Van Belkum, M. J., Kok, J., and Venema, G., Cloning, sequencing, and expression in Escherichia coli of Icn B, a third bacteriocin determinant from the lactococcal bacteriocin plasmid p9B4-6, Appl. Environ. Microbiol., 1992; 58: 572-577.
103. Van Belkum, M. J., Hayema, B. J., Jeeninga, R. E., Kok, J., and Venema, G., Organization and nucleotide sequences of two lactococcal bacteriocin operons, Appl. Environ. Microbiol., 1991; 57: 492-498.
104. Klaenhammer, T. R., Genetics of bacteriocins produced by lactic acid bacteria, FEMS Microbiol. Rev., 1993; 12(1-3): 39-85.
105. Hastings, J. W. and Stiles, M. E., Antibiosis of Leuconostoc gelidum isolated form meat, J. Appl. Bacteriol., 1991; 70: 127-134.
106. Gonzalez, C. F., and Kunka, B. S., Plasmid-associated bacteriocin production and sucrose fermentation in Pediococcus acidilactici, Appl. Environ. Microbiol., 1987; 53: 2534-2538.
107. Joerger, M. C., and Klaenhammer, T. R., Characterization and purification of helveticin J and evidence for a chromosomally determined bacteriocin produced by Lactobacillus helveticus 481, J. Bacteriol., 1986; 167: 439-446.
108. Toba, T., Samant, S. K., Yoshioka, E., and Itoh, T., Reuterin 6, a new bacteriocin produced by Lactobacillus reuteri LA 6, Lett. Appl. Microbiol., 1991a; 13: 281-286.
109. Toba, T., Yoshioka, E., and Itoh, T., Lacticin, a bacteriocin produced by Lactobacillus delbrueckii subsp. lactis, Lett. Appl. Microbiol., 1991b; 12: 43-45.
110. Rammelsberg, M. and Radler, F., Antibacterial polypeptides of Lactobacillus species, J. Appl. Bacteriol., 1990; 69: 177-184.
111. Buchman, G. W., Banerjee, S., and Hansen, J. N., Structure, expression, and evolution of a gene encoding the precursor of nisin, a small protein antibiotic, J. Biol. Chem., 1988; 263: 16260-16266.
112. Mulders, J. W. M., Boerrigter, I. J., Rollema, H. S., Siezen, R. J., and de Vos, W. M., Identification and characterization of the lantibiotic nisin Z, a natural nisin variant, Eur. J. Biochem., 1991; 201: 581-584.
113. Mortvedt, C. I. and Nes, I. F., Plasmid-associated bacteriocin production by a Lactobacillus sake strain, J. Gen. Microbiol., 1990; 136: 1601-1607.
114. Piard, J. C., Delorme, F., Giraffa, G., Commissaire, J., and Desmazeaud, M., Evidence for a bacteriocin produced by Lactococcus lactis CNRZ 481, Neth. Milk Dairy J., 1990; 44: 143-158.
115. Stoffels, G., Nissen-Meyer, J., Gudmundsdottir, A., Sletten, K., Holo, H., and Nes, I. F., Purification and characterization of a new bacteriocin isolated from a Carnobacterium sp., Appl. Environ. Microbiol., 1992; 58: 1417-1422.
116. Jimenez-Diaz, R., Ruiz-Barba, J. L., Cathcart, D. P., Holo, H., Nes, I. F., Sletten, K. H., and Warner, P. J., Purification and partial amino acid sequence of plantaricin S, a bacteriocin produced by Lactobacillus plantarum LPCO10, the activity of which depends on the complementary action of two peptides, Appl. Environ. Microbiol., 1995; 61(12): 4459-4463.
117. Casaus, P., Nilsen, T., Cintas, L. M., Nes, I. F., Hernandez, P. E., and Holo, H., Enterocin B, a new bacteriocin from Enterococcus faecium T136 which can act synergistically with enterocin A, Microbiology, 1997; 143: 2287-2294.
118. Hurst, A., Nisin, Adv. Appl. Microbiol., 1981; 27 85-123.
119. Wolf, B. W., Garleb, K. A., Ataya, D. G., and Casas, I. A., Safety and tolerance of Lactobacillus reuten in healthy adult male subjects, Micro. Ecol. Hlth. Dis., 1995; 8: 41-50.
120. Ruiz-Palacios, G., Tuz, F., Arteaga, F., Guerrero, M. L., Dohnalek, M., and Hilty, M., Tolerance and fecal colonization with Lactobacillus reuteri in children fed a beverage with a mixuture of Lactobacillus spp., Pediatr. Res., 1996; 39(4): 184A(Abstract #1090)
121. Speck, M. L., Dobrogosz, W. J., and Casas, I. A., Lactobacillus reuteri in food supplementation, Food Technol., 1993; (July): 90, 92-94.
122. Fleming, H. P., McFeeters, R. F., and Daeschel, M. A., The lactobacilli, pediococci, and leuconostocs: vegetable products. In: Bacterial starter cultures for foods, Gilliland, S. E., Ed., CRC Press Inc., Boca Raton, Florida, 1986, 97-118.
123. London, J., Uncommon pathways of metabolism among lactic acid bacteria, FEMS Microbiol. Rev., 1990; 87: 103-112.
124. Poolman, B., Energy transduction in lactic acid bacteria., FEMS Microbiol. Rev., 1993; 12: 125-147.
125. Eklund, T., The effect of carbon dioxide on bacterial growth and on uptake processes in the bacterial membrane vesicles, Int. J. Food Microbiol., 1984; 1: 179-185.
126. Clark, D. S. and Takacs, J., Gases as preservatives. In: Microbial ecology of foods, Sillikier, J. H., Ed., Academic Press, London, 1980, 170-180.
127. Condon, S., Responses of lactic acid bacteria to oxygen, FEMS Microbiol. Rev., 1987; 46: 269-280.
128. Hugenholtz, J., Citrate metabolism in lactic acid bacteria, FEMS Microbiol. Rev., 1993; 12: 165-178.
129. Jay, J. M., Antimicrobial properties of diacetyl, Appl. Environ. Microbiol., 1982; 44: 525-532.
130. Jay, J. M., Modern food microbiology, 5th ed.,Chapman & Hall, New York, 1996.
131. Gupta, K. G., Chandiok, L., and Bhatnagar, L., Antibacterial activity of diacetyl and its influence on the keeping quality of milk, Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. (Abt. 1 Orig. Reihe B), 1973; 158: 202-205.
132. Spillman, H., Puhan, Z., and Banhegyi, M., Antimikrobielle aktivitat thermophiler Lactobazillen, Milchwissenschaft, 1978; 33: 148-153.
133. Motlagh, A. M., Johnson, M. C., and Ray, B., Viability loss of foodborne pathogens by starter culture metabolites, J. Food Prot., 1991; 54: 873-878, 884.
134. Kulshrestha, D. A. and Marth, E. H., Inhibition of bacteria by some volatile and non-volatile compounds associated with milk. I. Escherichia coli, J. Milk Food Technol., 1974a; 37: 510-516.
135. Kulshrestha, D. C., and Marth, E. H., Inhibition of bacteria by some volatile and non-volatile compounds associated with milk. II. Salmonella typhimurium., J. Milk Food Technol., 1974b; 37: 539-544.
136. Kulshrestha, D. C. and Marth, E. H., Inhibition of bacteria by some volatile and non-volatile compounds associated with milk. III. Stapylococcus aureus, J. Milk Food Technol., 1974c; 37: 545-550.
137. Savage, D. C., Microbial interference between indigenous yeast and lactobacilli in the rodent stomach, J Bacteriol., 1969; 98: 1278-1283.
138. Ducluzeau, R., Dubos, F., and Raibaud, P., Antagonist effect of a Lactobacillus strain on a Ristella sp. strain in the digestive tract of gnotoxenic mice ingesting lactose, Ann. Inst. Pasteur (Paris), 1971; 121: 777-794.
139. Sato, K., Enhancement of host resistance against Listeria infection by Lactobacillus casei: role of macrophages, Infect. Immun., 1984; 44: 445-451.
140. Sato, K., Saito, H., and Tomioka, H., Enhancement of host resistance against Listeria infection by Lactobacillus casei: activation of liver macrophages and peritoneal macrophages by Lactobacillus casei, Microbiol. Immunol., 1988a; 32: 689-698.
141. Itoh, K. and Freter, R., Control of Escherichia coli populations by a combination of indigenous clostridia and lactobacilli in gnotobiotic mice and continuous-flow cultures, Infect. Immun., 1989; 57: 559-565.
142. Fichera, G. A., Pappalardo, C., Furneri, P. M., Gismondo, M. R., and Nicoletti, G., Evaluation of antinfective activity of an association bifidobacterium/lactobacillus in mouse intestine, G. Batteriol. Virol. Immunol., 1987; 80: 189-205.
143. De Simone, C., Tzantzoglou, S., Baldinelli, L., Di Fabio, S., Bianchi-Salvadori, B., Jirillo, E., and Vesely, R., Enhancement of host resistance against Salmonella typhimurium infection by a diet supplemented with yogurt, Immunopharmacol. Immunotoxicol., 1988; 10: 399-415.
144. Perdigon, G., Nader de Macias, M. E., Alvarez, S., Oliver, G., and Pesce de Ruiz Holgado, A. A., Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus, J. Dairy Res., 1990; 57: 255-264.
145. Perdigon, G., Alvarez, S., and Pesce de Ruiz Holgado, A., Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections, J. Dairy Res., 1991; 58: 485-496.
146. Nader de Macias, M. E., Apella, M. C., Romero, N. C., Gonzalez, S. N., and Oliver, G., Inhibition of Shigella sonnei by Lactobacillus casei and Lactobacillus acidophilus, J. Appl. Bacteriol., 1992; 73: 407-411.
147. Hudault, S., Lievin, V., Bernet-Camard, M. F., and Servin, A. L., Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection, Appl. Environ. Microbiol., 1997; 63; 513-518.
148. Rani, B. and Khetarpaul, N., Probiotic fermented food mixtures: possible applications in clinical anti-diarrhoea usage, Nutr. Hlth., 1998; 12: 97-105.
149. Kabir, A. M., Aiba, Y., Takagi, A., Kamiya, S., Miwa, T., and Koga, Y., Prevention of Helicobacter pylon infection by lactobacilli in a gnotobiotic murine model, Gut, 1997; 41: 49-55.
150. Alak, J. I., Wolf, B. W., Mdurvwa, E. G., Pimentel-Smith, G. E., and Adeyemo, O., Effect of Lactobacillus reuteri on intestinal resistance of Cryptosporidium parvum infection in a murine model of acquired immunodeficiency syndrome, J. Infect. Dis., 1997; 175: 218-221.
151. Wagner, R. D., Pierson, C., Warner, T., Dohnalek, M., Farmer, J., Roberts, L., Hilty, M., and Balish, E., Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice, Infect. Immun., 1997; 65: 4165-4172.
152. Miake, S., Nomoto, K., Yokokura, T., Yoshikai, Y., Mutai, M., and Nomoto, K., Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice, Infect. Immun., 1985; 48: 480-485.
153. Setoyama, T., Nomoto, K., Yokokura, T., and Mutai, M., Protective effect of lipoteichoic acid from Lactobacillus casei and Lactobacillus fermentum against Pseudomonas aeruginosa in mice, J. Gen. Mlcrobiol., 1985; 131: 2501-2503.
154. Nomoto, K., Miake, S., Hashimoto, S., Yokokura, T., Mutai, M., Yoshikai, Y., and Nomoto, K., Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei, J. Clin. Lab. Immunol., 1985; 17: 91-97.
155. Sato, K., Saito, H., Tomioka, H., and Yokokura, T., Enhancement of host resistance against Listeria infection by Lactobacillus casei: efficacy of cell wall preparation of Lactobacillus casei, Microbiol. Immunol., 1988b; 32: 1189-1200.
156. Saito, H., Tomioka, H., and Nagashima, K., Protective and therapeutic efficacy of Lactobacillus casei against experimental murine infections due to Mycobacterium fortuitum complex, J. Gen. Microbiol., 1987; 133: 2843-2851.
157. Fourniat, J., Djaballi, Z., Maccario, J., Bourlioux, P., and German, A., Effect of the administration of killed Lactobacillus acidophilus on the survival of suckling mice infected with a strain of enterotoxigenic Escherichia coli, Ann. Rech. Vet., 1986; 17: 401-407.
158. Shkarupeta, M. M., Korshunov, V. M., Savenkova, V. T., and Pinegin, B. V., Influence of the oral administration of indigenous microorganisms on the resistance of mice to Salmonella infection, Zh. Mikrobiol. Epidemiol. Immunobiol., 1988; 7: 46-50.
159. Ishihara, K., Miyakawa, H., Hasegawa, A., Takazoe, I., and Kawai, Y., Growth inhibition of Streptococcus mutans by cellular extracts of human intestinal lactic acid bacteria, Infect. Immun., 1985; 49: 692-694.
160. Coconnier, M. H., Lievin, V., Bernet-Camard, M. F., Hudault, S., and Servin, A. L., Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB, Antimicrob. Agents Chemother., 1997; 41: 1046-1052.
161. Watanabe, T. and Saito, H., Protection of mice against herpes simplex virus infection by a Lactobacillus casei preparation (LC 9018) in combination with inactivated viral antigen, Microbiol Immunol., 1986; 30: 111-122.
162. Watanabe, T., and Yamori, T., Primary resistance induced in mice by Lactobacillus casei following infection with herpes simplex virus, Kansenshogaku Zasshi, 1989; 63: 182-188.
163. Ohashi, T., Yoshida, A., and Minamishima, Y., Host-mediated antiviral activity of Lactobacillus casei against cytomegalovirus infection in mice, Biotherapy, 1988; 1: 27-39.
164. Ohashi, T., Minamishima, Y., Yokokura, T., and Mutai, M., Induction of resistance in mice against murine cytomegalovirus by cellular components of Lactobacillus casei. Biotherapy, 1989; 1(2): 89-95.
165. Saito, H., Nagashima, K., and Tomioka, H., Effects of bacterial immunopotentiators, LC 9018 and OK-432, on the resistance against Mycobacterium intracellular infection in mice, Hiroshima J. Med. Sci., 1983a; 32: 145-148.
166. Watanabe, T. and Hotta, T., Suppressive effects of Lactobacillus casei cells, a bacterial immunostimulant, on the incidence of spontaneous thymic lymphoma in AKR mice, Cancer Immunol. Immunother., 1996; 42: 285-290.
167. Silva de Ruiz, C., Lopez de Bocanera, M. E., Nader de Macias, M. E., and Pesce de Ruiz Holgado, A. A., Effect of lactobacilli and antibiotics on E. coli urinary infections in mice, Biol. Pharm. Bull., 1996; 19: 88-93.
168. Salminen, S., Isolauri, E., and Salminen, E., Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges, Antonie Van Leeuwenhoek, 1996; 70: 347-358.
169. Reid, G., Bruce, A. W., McGroarty, J. A., Cheng, K. J., and Costerton, J. W., Is there a role for lactobacilli in prevention or urogenital and intestinal infection? Clin. Microbiol. Rev., 1990; 3(4): 335-344.
170. Chan, R. C., Bruce, A. W., and Reid, G., Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of Gram-negative uropathogens by competitive exclusion, J. Urol., 1984; 131: 596-601.
171. Reid, G., Cook, R. L., and Bruce, A. W., Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract, J. Urol., 1987; 138: 330-335.
172. Hawthorn, L. A. and Reid, G., Exclusion of uropathogen adhesion to polymer surfaces by Lactobacillus acidophilus, J. Biomed. Mater. Res., 1990; 24: 39-46.
173. Reid, G., Tieszer, C., and Lam, D., Influence of lactobacilli on the adhesion of Staphylococcus aureus and Candida albicans to fibers and epithelial cells, J. Ind. Microbiol., 1995; 15: 248-253.
174. Velraeds, M. M., van der Mei, H. C., Reid, G., and Busscher, H. J., Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates, Appl. Environ. Microbiol., 1996; 62: 1958-1963.
175. Velraeds, M. M., van der Mei, H. C., Reid, G., and Busscher, H. J., Inhibition of initial adhesion of uropathogenic Enterococcus faecalis to solid substrata by an adsorbed biosurfactant layer from Lactobacillus acidophilus, Urology, 1997; 49: 790-794.
176. Wilcox, M. D., Patrikakis, M., Harty, D. W., Loo, C. Y., and Knox, K. W.,
177. Foumiat, J., Colomban, C., Linxe, C., and Karam, D., Heat-killed Lactobacillus acidophilus inhibits adhesion of Escherichia coli B41 to HeLa cells, Ann. Rech. Vet., 1992; 23: 361-370.
178. Chauviere, G., Coconnier, M. H., Kernels, S., Darfeuille-Micharud, A., Joly, B., and Servin, A. L., Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus, FEMS Microbiol. Lett., 1992; 70: 213-217.
179. Coconnier, M. H., Bernet, M. F., Kerneis, S., Chauviere, G., Fourniat, J., and Servin, A. L., Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion, FEMS Microbiol. Lett., 1993a; 110: 299-305.
180. Bernet, M. F., Brassart, D., Neeser, J. R., and Servin, A. L., Lactobadllus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria, Gut, 1994; 35:483-489.
181. Coconnier, M. H., Bernet, M. F., Chauviere, G., and Servin, A. L., Adhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestianl cells, J. Diarrhoeal Dis. Res., 19935; 11: 235-242.
182. Blomberg, L., Henriksson, A., and Conway, P. L., Inhibition of adhesion of Escherichia coli K88 to piglet ileal mucus by Lactobacillus spp., Appl. Environ. Microbiol., 1992; 59: 34-39.
183. Jin, L. Z., Ho, Y. W., Ali, M. A., Abdullah, N., and Jalaludin, S., Effect of adherent Lactobacillus spp. on in vitro adherence of salmonellae to the intestinal epithelial cells of chicken, J. Appl. Bacteriol., 1996; 81: 201-206.
184. Cummings, J. H. and MacFarlane, G. T., Colonic microflora: nutrition and health, Nutr., 1997; 13: 476-478.
185. Cummings, J. H. and Branch, W. J., Fermentation and the production of short chain fatty acids in the human large intestine. In: Dietary fiber: basic and clinical aspects, Vahouny, G. and Kritchevsky, D., Eds., Plenum Press, New York and London, 1986, 131-149.
186. Rombeau, J. L., Kripke, S.A., and Settle, R. G., Short-chain fatty acids. Production, absorption, metabolism and intestinal effects. In: Dietary fiber: chemistry, physiology, and health effects, Kritchevsky, D., et al., Ed., Plenum Press, New York and London, 1990, 317-337.
187. Leavitt, J., Barrett, J. C., Crawford, B.D., and Tso, P. O. P., Butyric acid suppression on the in vitro neoplastic state of Syrian hamster cells, Nature, 1978; 271: 262.
188. Fukushima, T., Kawamoto, M., Ishiguro, N., Kubo, A., and Tsuchiya, S., Short-chain fatty acid in intestinal obstruction, Jpn. J. Surg., 1983; 13: 117-121.
189. Mallett, A. K., Bearne, C. A., and Rowland, I. R., The influence of incubation pH on the activity of rat and human gut flora enzymes, J. Appl. Bacteriol., 1989; 66: 433-437.
190. Kilara, A. and Shahani, K. M., Lactase activity of cultured and acidified dairy products, J. Dairy Sci., 1975; 59: 2031-2035.
191. Gilliland, S. E., and Kim, H. S., Effect of viable starter culture bacteria in yogurt on lactose utilization in humans, J. Dairy Sci., 1984; 67: 1-6.
192. Kolars, J. C., Levitt, M. D., Aouji, M., and Savaiano, D. A., Yogurt - an autodigesting source of lactose, N. Engl. J. Med., 1984; 310(1): 1-3.
193. Marteau, P., Flourie, B., Pochart, P., Chastange, C., Desjeux, J.-F., and Rambaud, J.-C., Effect of the microbial lactase (EC 3.2.1.23) activity in yoghurt on the intestinal absorption of lactose: an in vivo study in lactase-deficient humans, Br. J. Nutr., 1990a; 64: 71-79.
194. Sanders, M. E., Lactic acid bacteria as promoters of human health. In: Functional foods: designer foods, pharmafoods, nutraceuticals, Goldberg, I., Ed., Chapman & Hall, New York, 1994, 294-322.
195. Lin, M.-Y., Savaiano, D., and Harlander, S., Influence of nonfermented dairy products containing bacterial starter cultures on lactose maldigestion in humans, J. Dairy Sci., 1991; 74: 87-95.
196. Martini, M. C., Kukielka, D., and Savaiano, D. A., Lactose digestion from yogurt: influence of a meal and additional lactose, Am. J. Clin. Nutr., 1991a; 53: 1253-1258.
197. Shermak, M. A., Saavedra, J. M., Jackson, T. L., Huang, S. S., Bayless, T. M., and Perman, J. A., Effect of yogurt on symptoms and kinetics of hydrogen production in lactosemalabsorbing children, Am. J. Clin. Nutr., 1995; 62: 1003-1006.
198. Jiang, T., Mustapham, A., and Savaiano, D. A., Improvement of lactose digestion in humans by ingestion of unfermented milk containing Bifidobacterium longum, J. Dairy Sci., 1996; 79: 750-757.
199. Hove, H., Nordgaard-Andersen, I., and Mortensen P. B., Effect of lactic acid bacteria on the intestinal production of lactate and short-chain fatty acids, and the absorption of lactose, Am. J. Clin. Nutr., 1994; 59: 74-79.
200. Bennet, A. and Eley, K. G., Intestinal pH and propulsion: an explanation of diarrhoea in lactase deficiency and laxation by lactulose, J. Pharm. Pharmacol, 1976; 28: 192-195.
201. Seki, M., Igarashi T, Fukuda, Y., Simamura, S., Kaswashima, T., and Ogasa, K., The effect of Bifidobacterium cultured milk on the 'regularity' among, an aged group, Nutr. Foodstuff, 1978; 31: 379-387.
202. Alm, L., Ryd-Kjellén, E., Setterberg, G., and Blomquist, L., The effect of culture on constipation in geriatric patients, Food Search '92, The Royal Veterinary and Agricultural University, Copenhagen, January 1992.
203. Motta, L., Blancato, G., Scornavacca, G., De Luca, M., Vasquez, E., Gismondo, M. R., Lo Bue, A., and Chisari, G., Study on the activity of a therapeutic bacterial combination in intestinal motility disorders in the aged, Clin. Ter., 1991; 138: 27-35.
204. Gilliland, S. E. and Walker, D. K., Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans, J. Dairy Sci., 1990; 73: 905-911.
205. Noh, D. O., Kim, S. H., and Gilliland, S. E., Incorporation of cholesterol into the cellular membrane of Lactobacillus acidophilus ATCC 43121, J. Dairy Sci., 1997; 80: 3107-3113.
206. Brigidi, P., Bolognani, F., Rossi, M., Cerre, C., and Matteuzzi, D., Cloning of the gene for cholesterol oxidase in Bacillus spp., Lactobacillus reuteri and its expression in Escerichia coli, Lett. Appl. Microbiol., 1993; 17: 61-64.
207. Gilliland, S. E., Nelson, C. R., and Maxwell, C., Assimilation of cholesterol by Lactobacillus acidophilus, Appl. Environ. Microbiol., 1985; 49: 377-381.
208. Danielson, A. D., Peo, E. R. J., Shahani, K. M., Lewis, A. J., Whalen, P. J., and Amer, M. A., Anticholesterolemic property of Lactobacillus acidophilus yogurt fed to mature boars, J. Animal Sci., 1989; 67: 966-974.
209. Zacconi, C., Bottazzi, V., Rebecchi, A., Bosi, E., Sarra, P. G., and Tagliaferri, L., Serum cholesterol levels in axenic mice colonized with Enterococcus faecium and Lactobacillus acidophilus, Microbiologica, 1992; 15: 413-417.
210. Oda, T. and Hashiba, H., Effects of skim milk and its fermented product by Lactobacillus acidophilus on plasma and liver lipid levels in diet-induced hypertriglyceridemic rats, J. Nutr. Sci. Vitaminol. (Tokyo), 1994; 40: 617-621.
211. Fukushima, M. and Nakano, M., Effects of a mixture of organisms, Lactobacillus acidophilus or Streptococcus faecalis on cholesterol metabolism in rats fed on a fat- and cholesterol-enriched diet, Br. J. Nutr., 1996; 76: 857-867.
212. De Rodas, B. Z., Gilliland, S. E., and Maxwell, C. V., Hypocholesterolemic action of Lactobacillus acidophilus ATCC 43121 and calcium in swine with hypercholesterolemia induced by diet, J. Dairy Sci., 1996; 79:2121 -2128.
213. Akalin, A. S., Gone, S., and Duzel, S., Influence of yogurt and acidophilus yogurt on serum cholesterol levels in mice, J. Dairy Sci., 1997; 80: 2721-2725.
214. De Smet, I., De Boever, P., and Verstraete, W., Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity, Br. J. Nutr., 1998; 79: 185-194.
215. du Toit, M., Franz, C. M., Dicks, L. M., Schillinger, U., Haberer, P., Warlies, B., Ahrens, F., and Holzapfel, W. H., Characterization and selection of probiotic lactobacilli for a preliminary minipig feeding trial and their effect on serum cholesterol levels, feces pH and feces moisture content, Int. J. Food Microbiol., 1998; 40: 93-104.
216. Harrison, V. C. and Peat, G., Serum cholesterol and bowel flora in the newborn, Am. J. Clin. Nutr., 1975; 28: 1351-1355.
217. Lin, S. Y., Ayres, J. W., Winkler, W. J. R., and Sandine, W. E., Lactobacillus effects on cholesterol: in vitro and in vivo results, J. Dairy Sci., 1989; 72: 2885-2899.
218. Mohan, J. C., Arora, R., and Khalilullah, M., Short-term hypolipidemic effects of oral Lactobacillus sporogenes therapy in patients with primary dyslipidemias, Indian Heart J, 1990; 42: 361-364.
219. Hata, Y; Yamamoto, M; Ohni, M; Nakajima, K; Nakamura, Y; and Takano, T., A placebocontrolled study of the effect of sour milk on blood pressure in hypertensive subjects, Am. J. Clin. Nutr., 1996; 64: 767-771.
220. Matsuzaki, T., Yamazaki, R., Hashimoto, S., and Yokokura, T., Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice, Endocrin. J., 1997a; 44: 357-365.
221. Matsuzaki, T., Nagata, Y., Kado, S., Uchida, K., Hashimoto, S., and Yokokura, T., Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice, APMIS, 1997b; 105: 637-642.
222. Matsuzaki, T., Nagata, Y., Kado, S., Uchida, K., Kato, I., Hashimoto, S., and Yokokura, T., Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei, APMIS, 1997c; 105: 643-649.
223. Depuis, Y., Fermented milk and utilization of inorganic constituents, Ann. Bull. Int. Dairy Fed., 1964; 3: 36-43.
224. Seneca, H. and Gaymont, S., Clinical uses of yogurt, J. Am. Geriatr. Soc., 1957; 5: 932-935.
225. Bushnell, P. J. and DeLuca, H. F., Lactose facilitates the intestinal absorption of lead in weanling rats, Science, 1981; 211: 61-63.
226. Cochet, B., Jung, A., Griessen, M., Bartholdi, P., Schaller, P., and Donath, A., Effects of lactose on intestinal calcium absorption in normal and lactase-deficient subjects, Gastroenterology, 1983; 84: 935-940.
227. Sato, R., Noguchi, T., and Nato, H., Effect of lactose on calcium absorption from the rat small intestine with a non-flushed Hgated loop, J. Nutr. Sci. Vitaminol., 1983; 29: 365-373.
228. Savaiano, D. A. and Levitt, M. D., Nutritional and therapeutic aspects of fermented dairy products, J. Dent. Child., 1984; 51: 305-308.
229. Smith, T. M., Kolars, J. C., Savaiano, D. A., and Levitt, M. D., Absorption of calcium from milk and yogurt, Am. J. Clin. Nutr., 1985; 42: 1197-1200.
230. Newcomer, A. D., Hodgson, S. F., McGill, D. B., and Thomas, P. J., Lactase deficiency: prevalence in osteoporosis, Ann. Intern. Med., 1978; 89: 218-221.
231. Gorbach, S. L., Lactic acid bacteria and human health, Ann. Med., 1990; 22: 37-41.
232. Rajalakshmi, R. and Vanaji, K., Chemical and biological evaluation of the effects of fermentation on the nutritive value of foods prepared from rice and grain, Br. J. Nutr., 1967; 21: 467-473.
233. Shahani, K. M. and Chandan, R. C., Nutritional and healthful aspects of cultured and culture-containing dairy foods, J. Dairy Sci., 1979; 62: 1685-1694.
234. Deeth, H. C. and Tomine, A. Y., Yogurt: nutritive and therapeutic aspects, J. Food Protect., 1981; 44: 78-86.
235. Alm, L., Effect of fermentation on B-vitamin content of milk in Sweden, J. Dairy Sci., 1982; 65: 353-359.
236. Reddy, K. P., Shahani, K. M., and Kulkarni, S. M., B-complex vitamins in cultured and acidified yogurt, J. Dairy Sci., 1976; 59: 191-195.
237. Leim, I. T., Steinkraus, K. H., and Cronk, T. C., Production of vitamin B-12 in tempeh, a fermented soybean food, Appl. Environ. Microbiol., 1977; 34: 773-776.
238. Shane, B., Bognar, A. L., Goldfarb, R. D., and LeBowitz, J. H., Regulation of folylpoly-gamma-glutamate synthesis in bacteria: in vivo and in vitro synthesis of pteroylpoly-gamma-glutamates by Lactobacillus casei and Streptococcus faecalis, J Bacteriol., 1983; 153: 316-325.
239. Nair, C. P. and Noronha, J. M., Folylpolyglutamate synthetase in Lactobacillus leichmannii: in vitro synthesis and characterization of polyglutamylfolates, Indian J. Biochem. Biophys., 1994; 31: 469-472.
240. Alm, L., Effect of fermentation on B-vitamin content of milk in Sweden, J. Dairy Sci., 1982; 65: 353-359.
241. Fredrickson, A. G., Behavior of mixed cultures of organisms, Ann. Rev. Med. Microbiol., 1977; 31: 63-87.
242. Elliker, P. R., Sandine, W. E., Hauser, B. A., and Moseley, W. K., Influence of culturing cottage cheese dressing with different organisms on flavor and keeping quality, J. Dairy Sci., 1964; 47: 680.
243. Iandolo, J. J., Clark, C. W., Bluhm, L., and Ordal, Z. J., Repression of Staphylococcus aureus in associative culture, Appl. Microbiol., 1965; 13: 646-649.
244. Wilson, K. H., and Perini, P., Role of competition for nutrients in suppression of Clostridium difficile by the clonic microflora, Infect. Immun., 1988; 56: 2610-2614.
245. Degnan, A. J., Yousef, A. E., and Luchansky, J. A., Use of Pediococcus acidilacitci to control Listeria monocytogenes in temperatureabused vacuum-packaged wieners, J. Food Protect., 1992; 55: 98-103.
246. Bezkorovainy, A. and Solberg, L., Ferrous iron uptake by Bifidobacterium breve, Biol. Trace Elem. Res., 1989; 20: 251-267.
247. Bloksma, N., de Heer, E., Van Dijk, H., and Willers, J. M., Adjuvanticity of lactobacilli. I. Differential effects of viable and killed bacteria, Clin. Exp. Immunol., 1979; 37: 367-375.
248. Bloksma, N., Ettekoven, H., Hofhuis, F. M., van Noorle-Jansen, L., De Reuver, M. J., Kreeftenberg, J. G., and Willers, J. M., Effects of lactobacilli on parameters of non-specific resistance of mice, Med. Microbiol. Immunol. (Berlin), 1981; 170: 45-53.
249. Shimizu, T., Mifuchi, I., and Yokokura, T., Mitogenic effect of lactobacilli on murine lymphocytes, Chem. Pharm. Bull. (Tokyo), 1981; 29: 3731-3734.
250. Kato, I., Yokokura, T., and Mutai, M., Macrophage activation by Lactobacillus casei in mice, Microbiol. Immunol., 1983; 27: 611-618.
251. Saito, H., Sato, K., Horikawa, Y., Jin, B. W., Tomioka, H., and Watanabe, T., Enhanced humoral antibody production and delayed type hypersensitivity response in mice by Lactobacillus casei, Hiroshima J. Med. Sci., 1983b; 32: 223-226.
252. Kalo, I., Yokokura, T., and Mutai, M., Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens, Microbiol. Immunol., 1984; 28: 209-217.
253. Hashimoto, S., Nomoto, K., Matsuzaki, T., Yokokura, T., and Mutai, M., Oxygen radical production by peritoneal macrophages and Kupffer cells elicited with Lactobacillus casei, Infect. Immun., 1984; 44: 61-67.
254. Kato, I., Yokokura, T., and Mutai, M., Induction of tumoricidal peritoneal exudate cells by administration of Lactobacillus casei. Int. J. Immunopharmacol., 1985; 7: 103-109.
255. Yasutake, N., Ohwaki, M., Mutai, M., Koide, Y., and Yoshida, T., Anti-tumour effect of humoral and cellular immunities medicated by a bacterial immunopotentiator, Lactobacillus casei, in mice, Cancer Immunol. Immunother., 1985; 20: 109-116.
256. Hashimoto, S., Seyama, Y., Yokokura, T., and Mutai, M., Cytotoxic factor production by Kupffer cells elicited with Lactobacillus casei and Corynebacterium parvum, Cancer Immunol. Immunother., 1985; 20: 117-121.
257. Yokokura, T., Nomoto, K., Shimizu, T., and Nomoto, K., Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei. Infect. Immun., 1986; 52: 156-160.
258. Nanno, M., Ohwaki, M., and Mutai, M., Induction by Lactobacillus casei of increase in macrophage colony-forming cells and serum colony-stimulating activity in mice, Jpn. J. Cancer Res., 1986; 77: 703-710.
259. Perdigon, G., de Macias, M. E., Alvarez, S., Oliver, G., and de Ruiz Holgado, A. A., Effect of perorally administered lactobacilli on macrophage activation in mice, Infect. Immun., 1986; 53: 404-410.
260. Zaitseva, L. G., Gorskaia, E. M., Lentsner, A. A., and Shustrova, N. M., Enhancement of the phagocytic activity of cells of the mononuclear phagocytosing system by the peroral administration of lactobacilli, Antibiot. Med. Biotekhnol., 1986; 31: 691-694.
261. Perdigon, G., Nader de Macias, M. E., Alvarez, S., Oliver, G., and Pesce de Ruiz Holgado, A. A., Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus, J. Dairy Sci., 1987; 70: 919-926.
262. Nanno, M., Shimizu, T., Mike, A., Ohwaki, M., and Mutai, M., Role of macrophages in serum colony-stimulating factor induction by Lactobacillus casei in mice, Infect. Immun., 1988; 56: 357-362.
263. Perdigon, G., Alvarez, S., Nader de Macias, M. E., and Pesce de Ruiz Holgado, A. A., Adjuvant activity of lactic bacteria: perspectives for its use in oral vaccines, Rev. Agent Microbiol., 1988a; 20: 141-146.
264. Perdigon, G., de Macias, M. E., Alvarez, S., Oliver, G., and de Ruiz Holdado, A. A., Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus, Immunology, 1988b; 63: 17-23.
265. Suzuki, F., Okabe, H., Todaka, T., Hayashi, K., Koide, F., Maeda, H., and Ishida, N., Heat-killed Lactobacillus casei, LC-9018, as an interferon inducer, Nippon Saikingaku Zasshi, 1988; 43: 821-827.
266. Pereyra, B. S., Falcoff, R., Falcoff, E., and Lemonnier, D., Interferon induction by Lactobacillus bulgaricus and Streptococcus thermophilus in mice, Eur. Cytokine Netw, 1991; 2: 299-303.
267. Kitazawa, H., Matsumura, K., Itoh, T., and Yamaguchi, T., Interferon induction in murine peritoneal macrophage by stimulation with Lactobacillus acidophilus, Microbiol. Immunol., 1992; 36: 311-315.
268. Nanno, M., Shimizu-Takeda, T., Mike, A., Ohwaki, M., Togashi, Y., Suzuki, R., Kumagai, K., and Mutai, M., Increased production of cytotoxic macrophage progenitors by Lactobacillus casei in mice, J. Leukoc. Biol., 1989; 46: 89-95.
269. Davidkova, G., Popova, P., Guencheva, G., Bogdanov, A., Pacelli, E., Auteri, A., and Mincheva, V., Endogenous production of tumor necrosis factor in normal mice orally treated with Deodan - a preparation from Lactobacillus bulgaricus LB51, Int. J. Immunopharmacol., 1992; 14: 1355-1362.
270. Popova, P., Guencheva, G., Davidkova, G., Bogdanov, A., Pacelli, E., Opalchenova, G., Kutzarova, T., and Koychev, C., Stimulating effect of DEODAN (an oral preparation from Lactobacillus bulgaricus ("LB51") on monocytes/macrophages and host resistance to experimental infections, Int. J. Immunopharmacol., 1993; 15: 25-37.
271. Hatcher, G. E. and Lambrecht, R. S., Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria, J. Dairy Sci., 1993; 76: 2485-2492.
272. Pouwels, P. H., Leer, R. J., and Boersma, W. J., The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens, J. Biotechnol., 1996; 44: 183-192.
273. Furuse, M., Tsuneoka, K., Uchida, K., and Nomoto, K., Acceleration of granulocytic cell recovery in irradiated mice by a single subcutaneous injection of a heat-killed Lactobacillus casei preparation, J. Radiat. Res. (Tokyo), 1997; 38: 111-120.
274. Rangavajyala, N., Shahani, K. M., Sridevi, G., and Srikumaran, S., Nonlipopolysaccharide component(s) of Lactobacillus acidophilus stimulate(s) the production of interleukin-1 alpha and tumor necrosis factor-alpha by murine macrophages, Nutr. Cancer, 1997; 28: 130-134.
275. Shida, K., Makino, K., Morishita, A., Takamizawa, K., Hachimura, S., Ametani, A., Sato, T., Kumagai, Y., Habu, S., and Kaminogawa, S., Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures, Int. Arch. Allergy Immunol., 1998; 115: 278-287.
276. Kato, I., Yokokura, T., and Mutai, M., Correlation between increase in la-bearing macrophages and induction of T-cell-dependent antitumor activity by Lactobacillus casei in mice, Cancer Immunol. Fmmunother., 1988; 26: 215-221.
277. Matsuzaki, T., Yamazaki, R., Hashimoto, S., and Yokokura, T., The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice, J. Dairy Sci., 1998; 81: 48-53.
278. Prokopev, A. A., Kalinina, N. M., Andreev, S. V., Ishchenko, A. M., and Ketlinskii, S. A., Peptidoglycan isolated from Lactobacillus bulgaricus: its effect, mediated by the complement system, on pre-T-cell maturation, Biull. Eksp. Biol., Med., 1987; 104: 492-494.
279. Fichera, G. A. and Giese, G., Non-immunologically mediated cytotoxicity of Lactobacillus casei and its derivative peptidoglycan against tumor cell lines, Cancer Lett., 1994; 85: 93-103.
280. Nomoto, K., Nagaoka, M., Yokokura, T., and Mutai, M., Augmentation of resistance of mice to bacterial infection by a polysaccharidepeptidoglycan complex (PSPG) extracted from Lactobacillus casei, Biotherapy, 1989; 1: 169-177.
281. Kitazawa, H., Harata, T., Ulemura, J., Saito, T., Kaneko, T., and Itoh, T., Phosphate group requirement for mitogenic activation of lymphocytes by an extracellular phosphopolysaccharide from Lactobacillus delbrueckii ssp. bulgaricus, Int. J. Food Microbiol., 1998; 40: 169-175.
282. Famularo, G., Moretti, S., Marcellini, S., and De Simone, C., Stimulation of immunity by probiotics. In: Probiotics 2: Applications and practical aspects, Fuller, R., Ed., Chapman & Hall, New York, 1997, 133-161.
283. Kaila, M., Isolauri, E., Soppi, E., Virtanen, E., Laine, S., and Arvilommi, H., Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain, Pediatr. Res., 1992; 32: 141-144.
284. Majamaa, H., Isolauri, E., Saxelin, M., and Vesikari, T., Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis, J. Pediatr. Gastroenterol. Nutr., 1995; 20:333-338.
285. Isolauri, E., Joesnuu, J., Suomalainen, H., Luomala, M., and Vesidari, T., Improved immunogenicity of oral D×RRV reassortant rotavirus vaccine by Lactobacillus casei GG, Vaccine, 1995; 13: 310-312.
286. De Simone, C., Ciardi, A., Grassi, A., Gardini, S. L., Tzantzoglou, S., Trinchieri, V., Moretti, S., and Jirillo, E., Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes, lmmunopharmacol. Immunotoxicol., 1992; 14: 331-340.
287. Link-Amster, H., Rochat, F., Saudan, K. Y., Mignot, O., and Aeschlimann, J. M., Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake, FEMS Immunol. Med. Micro., 1994; 10: 55-64.
288. Schiffrin, E. J., Rochat, F., Link-Amster, H., Aeschlimann, J. M., and Donnet-Hughes, A., Immunomodulation of human blood cells following the ingestion of lactic acid bacteria, J. Dairy Sci., 1995; 78: 491-497.
289. Pestka, J. J., Food, diet, and gastrointestinal immune function, Adv. Food Nutr. Res., 1993; 37: 1-66.
290. Yasui, H., Nagaoka, N., Mike, A., Hayakawa, K., and Ohwaki, M., Detection of Bifidobacterium strains that induce large quantities of IgA, Micro. Ecol. Hlth. Dis., 1992; 5: 155-162.
291. Fernandes, C. F., Shahani, K. M., and Amer, M. A., Therapeutic role of dietary lactobacilli and lactobacillic fermented dairy products, FEMS Microbiol. Rev., 1987; 46: 343-356.
292. Renner, H. W. and Münzner, R., The possible role of probiotics as dietary antimutagens, Mutat. Res., 1991; 262: 239-245.
293. Lidbeck, A., Nord, C. E., Gustafsson, J. A., and Rafter, J., Lactobacilli, anticarcinogenic activities and human intestinal microflora, Eur. J. Cancer Prev., 1992; 1: 341-353.
294. Hosono, A., Kashina, T., and Kada, T., Antimutagenic properties of lactic acid-cultured milk on chemical and fecal mutagens, J. Dairy Sci., 1986; 69: 2237-2242.
295. Bodana, A. R., and Rao, D. R., Antimutagenic activity of milk fermented by Streptococcus thermophilus and Lactobacillus bulgaricus, J. Dairy Sci., 1990; 73: 3379-3384.
296. Hosoda, M., Hashimoto, H., Monta, H., Chiba, M., and Hosono, A., Antimutagenicity of mulk cultured with lactic acid bacteria against N-methyl-n′-nitro-N-nitrosoguanidine, J. Dairy Sci., 1992; 75: 976-981.
297. Nadathur, S. R., Gould, S. J., and Bakalinsky, A. T., Antimutagenicity of fermented milk, J. Dairy Sci., 1994; 77: 3287-3295.
298. Lankaputhra, W. E. and Shah, N. P., Antimutagenic properties of probiotic bacteria and of organic acids, Mutat. Res., 1998; 397: 169-182.
299. Hosoda, M., Hashimoto, H., He, F., Morita, H., and Hosono, A., Effect of administration of milk fermented with Lactobacillus acidophilus LA-2 on fecal mutagenicity and microflora in the human intestine, J. Dairy Sci., 1996; 79: 745-749.
300. Simenhoff, M. L., Dunn, S. R., Zollner, G. P., Fitzpatrick, M. E. D., Emery, S. M., Sandine, W. E., and Ayres, J. W., Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus, Miner. Electrolyte Metab., 1996; 22: 92-96.
301. Gourama, H. and Bullerman, L. B., Antiaflatoxigenic activity of Lactobacillus casei pseudoplantarum, Int. J. Food Microbiol., 1997; 34: 131-143.
302. Hawksworth, G., Drasar, B. S., and Hill, M. J., Intestinal bacteria and the hydrolysis of glycosidic bonds, J. Med. Microbiol., 1971; 4: 451-459.
303. Goldin, B. R. and Gorbach, S. L., Alterations in fecal microflora enzymes related to diet, age, lactobacillus supplements, and dimethylhydrazine, Cancer, 1977; 40: 2421-2426.
304. Marteau, P., Pochart, P., Flourié, B., Pellier, P., Santos, L., Desjeux, J.-F., and Rambaud, J.-C., Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifldobacterium bifidum on metabolic activities of the colonic flora in humans, Am. J. Clin. Nutr., 1990b; 52: 685-688.
305. Ling, W. H., Hänninen, O., Mykkänen, H., Heikura, M., Salminen, S., and VonWright, A., Colonization and fecal enzyme activities after oral Lactobacillus GG administration in elderly nursing home residents, Ann. Nutr. Metab., 1992; 36: 162-166.
306. Ling, W. H., Korpela, R., Mykkanen, H., Salminen, S., and Hanninen, O., Lactobacillus strain GG supplementation decreases coIonic hydrolytic and reductive enzyme activities in healthy female adults, J. Nutr., 1994; 124: 18-23.
307. Goldin, B. R., Swenson, L., Dwyer, J., Sexton, M., and Gorbach, S. L., Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes, J. Natl. Cancer Inst., 1980; 64: 255-261.
308. Pool-Zobel, B. L., Bertram, B., Knoll, M., Lambertz, R., Neudecker, C., Schillinger, U., Schmezer, P., and Holzapfel, W. H., Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of rats, Nutr. Cancer, 1993a; 20: 271-281.
309. Pool-Zobel, B. L., Neudecker, C., Domizlaff, I., Ji, S., Schillinger, U., Rumney, C., Moretti, M., Vilarini, I., Scassellati-Sforzolini, R., and Rowland, I., Lactobacillus- and bifidobacterium-medicated antigenotoxicity in the colon of rats, Nutr. Cancer, 1996; 26: 365-380.
310. Zhang, X. B., and Ohta, Y., In vitro binding of mutagenic pyrolyzates to lactic acid bacterial cells in human gastric juice, J. Dairy Sci., 1991; 74: 752-757.
311. Vorobeva, L. I., Cherdyntseva, T. A., and Abilev, S. K., Antimutagenic action of bacterial culture liquid on mutagenesis induced by 2-nitrofluorene in Salmonella typhimurium strains, Genetika, 1995a; 31: 901-907.
312. Vorobeva, L. K., Cherdyntseva, T. A., and Abilev, S. K., Antimutagenic action of bacteria on mutagenesis induced by 4-nitrofluorene-1-oxide in Salmonella typhimurium, Mikorbiologiia, 1995b; 64: 228-233.
313. Hayatsu, H. and Hayatsu, T., Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human, Cancer Lett., 1993; 73: 173-179.
314. Thyagaraja, N. and Hosono, A., Binding properties of lactic acid bacteria from 'Idly' toward food-borne mutagens, Food Chem. Toxicol., 1994; 32: 805-809.
315. Orrhage, K., Silierström, E., Gustafsson, J.-Å., Nord, C. E., and Rafter, J., Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria, Mutat. Res., 1994; 311: 239-248.
316. Weirich-Schwaiger, H., Weirich, H. G., Kludas, M., and Hirsch-Kauffmann, M., Improvement of the DNA repair capacity of human fibroblasts by autolysates of Lactobacillus gasseri, Drug Res., 1995; 45: 342-344.
317. Terahara, M., Meguro, S., and Kaneko, T., Effects of lactic acid bacteria on binding and absorption of mutagenic heterocyclic amines, Biosci. Biotech. Biochem., 1998; 62: 197-200.
318. Sekine, K., Toida, T., Saito, M., Kuboyama, M., Kawashima, T., and Hashimoto, Y., A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice, Cancer Res., 1985; 45: 1300-1307.
319. Sekine, K., Watanabe-Sekine, E., Toida, T., Kasashima, T., Kataoka, T., and Hashimoto, Y., Adjuvant activity of the cell wall of Bifidobacrium infantis for in vivo immune responses in mice, Immunopharmacol. Immunotoxicol., 1994; 16: 589-609.
320. Sekine, K., Ohta, J., Onishi, M., Tatsuki, T., Shimokawa, Y., Toida, T., Kawashima, T., and Hashimoto, Y., Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifido-bacterium infantis, Biol. Pharm. Bull., 1995; 18: 148-153.
321. Mizutani, T., and Mitsuoka, T., Effect of intestinal bacteria on incidence of liver tumors in gnotobiotic C3H/He male mice, J. Natl. Cancer Inst., 1979; 63: 1365-1370.
322. Mizutani, T. and Mitsuoka, T., Inhibitory effect of some intestinal bacteria on liver tumorigenesis in gnotobiotic C3H/He male mice, Cancer Lett., 1980; 11: 89-95.
323. Bogdanov, I. G., Velichkov, V. T., Gurevich, A. I., Dalev, P. G., and Kolosov, M. N., Antitumor effect of glycopeptides from the cell wall of Lactobacillus bulgaricus, Bull. Exp. Biol. Med., 1977; 84: 709-712.
324. Ketlinskii, S. A., Prokop'eva, E. D., Prokop'ev, A. A., Artiukhov, A. I., and Pasechnik, V. A., Mechanism of the anti-tumoral effect of the blastolysin fraction isolated from Lactobacillus bulgaricus, Vopr. Onkol., 1987; 33:51-56.
325. Tomita, K., Akaza, H., Nomoto, K., Yokokura, T., Matsushima, H., Homma, Y., and Aso, Y., Influence of Lactobacillus casei on rat bladder carcinogenesis, Nippon Hinyokika Gakkai Zasshi, 1994; 85: 655-663.
326. Biffi, A., Corandini, D., Larsen, R., Riva, L., and Di Fronzo, G., Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line, Nutr. Cancer, 1997; 28: 93-99.
327. Gorbach, S. L., The intestinal microflora and its colon cancer connection, Infection, 1982; 10: 379-384.
328. Goldin, B. R. and Gorbach, S. L., Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats, J. Natl. Cancer Inst., 1980; 64: 263-265.
329. Shackelford, L. A., Rao, D. R., Chawan, C. B., and Pulusani, S. R., Effect of feeding fermented milk on the incidence of chemically induced colon tumors in rats, Nutr. Cancer, 1983; 5: 159-164.
330. van't Veer, P., Dekker, J. M., Lamers, J. W., Kok, F. J., Scheuten, E. G., Brants, H. A., Sturmans, F., and Hermus, R. J., Consumption of fermented milk products and breast cancer: a case-control study in The Netherlands, Cancer Res., 1989; 49: 4020-4023.
331. Pool-Zobel, B. L., Munzner, R., and Holzapfel, W. H., Antigenotoxic properties of lactic acid bacteria in the S. typhimurium mutagenicity assay, Nutr. Cancer, 1993b; 20: 261-270.
332. Kato, I., Kobayashi, S., Yokokura, T., and Mutai, M., Antitumor activity of Lactobacillus casei in mice, Gann, 1981; 72: 517-523.
333. Yasutake, N., Kato, I., Ohwaki, M., Yokokura, T., and Mutai, M., Host-mediated antitumor activity of Lactobacillus casei in mice, Gann, 1984a; 75: 72-80.
334. Matsuzaki, T., Yokokura, T., and Azuma, I., Anti-tumor activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs, Cancer Immunol. Immunother., 1985; 20: 18-22.
335. Asano, M., Karasawa, E., and Takayama, T., Antitumor activity of Lactobacillus casei (LC 9018) against experimental mouse bladder tumor (MBT-2), J. Urol., 1986; 136: 719-721.
336. Matsuzaki, T. and Yokokura, T., Inhibition of tumor metastasis of Leuis lung carcinoma in C57BL/6 mice by intrapleural administration of Lactobacillus casei, Cancer Immunol. Immunother., 1987a; 25: 100-104.
337. Hashimoto, S., Nomoto, K., Nagaoka, M., and Yokokura, T., In vitro and in vivo release of cytostatic factors from Lactobacillus casei-elicited peritoneal macrophages after stimulation with tumor cells and immunostimulants, Cancer Immunol. Immunother., 1987; 24: 1-7.
338. Matsuzaki, T., Yokokura, T., and Azuma, I., Antimetastatic effect of Lactobacillus casei YIT9018 (LC9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice, Cancer Immunol. Immunother., 1987b; 24: 99-105.
339. Matsuzaki, T., Yokokura, T., and Mutai, M., Antitumor effect of intrapleural administration of Lactobacillus casei in mice, Cancer Immunol. Immunother., 1988a; 26: 209-214.
340. Matsuzaki, T., Yokokura, T., and Mutai, M., The role of lumph node cells in the inhibition of metastasis by subcutaneous injection of Lactobacillus casei in mice, Med. Microbiol. Immunol. (Berlin), 1988b; 177: 245-253.
341. Okawa, T., Kita, M., Arai, T., Lida, K., Dokiya, T., Takegawa, Y., Hirokawa, Y., Yamazaki, K., and Hashimoto, S., Phase II randomized clinical trial of LC9018 concurrently used with radiation in the treatment of carcinoma of the uterine cervix. Its effect of tumor reduction and histology, Cancer, 1989; 64: 1769-1776.
342. Tohgo, A., Tanaka, N. G., Okada, H., and Osada, Y., Effect of combined intrapleural administration of Lactobacillus casei (LC9018) and adriamycin on experimental malignant pleurisy in mice, Jpn. J. Cancer Res., 1989; 80: 1238-1245.
343. Matsuzaki, T., Shimizu, Y., and Yokokura, T., Augmentation of antimetastatic effect on Lewis lung carcinoma (3LL) in C57BL/6 mice by priming with Lactobacillus casei, Med. Microbiol. Immunol. (Berlin), 1990; 179: 161-168.
344. Katayama, Y., The antitumor activity of Lactobacillus casei - the direct effects of L. casei to human tumor cell lines, Kansenshogaku Zasshì, 1990; 64: 781-786.
345. Aso, Y. and Akaza, H., Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer, Urol. Intl., 1992; 49: 125-129.
346. Okawa, T., Niibe, H., Arai, T., Sekiba, K., Noda, K., Takeuchi, S., Hashimoto, S., and Ogawa, N., Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix, Cancer, 1993; 72: 1949-1954.
347. Kato, I., Endo, K., and Yokokura, T., Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice, Int. J. Immunopharmacol., 1994; 16: 29-36.
348. Aso, Y., Akaza, H., Kotake, T., Tsukamoto, T., Imai, K., and Naito, S., Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial, Eur. Urol., 1995; 27: 104-109.
349. Watanabe, T. and Hotta, T., Suppressive effects of Lactobacillus casei cells, a bacterial immunostimulant, on the incidence of spontaneous thymic lymphoma in AKR mice, Cancer Immunol. Immunother., 1996; 42: 285-290.
350. Matsuzaki, T., Hashimoto, S., and Yokokura, T., Effects on antitumor activity and cytokine production in the thoracic cavity by intrapleural administration of Lactobacillus casei in tumor-bearing mice, Med. Microbiol. Immunol. (Berlin), 1996; 185: 157-161.
351. Yasutake, N., Ohwaki, M., Yokokura, T., and Mutai, M., Comparison of antitumor activity of Lactobacillus casei with other bacterial immunopotentiators, Med. Microbiol. Immunol. (Berlin), 1984b; 173: 113-125.
352. Shimizu, T., Nomoto, K., Yokokura, T., and Mutai, M., Role of colony-stimulating activity in antitumor activity of Lactobacillus casei in mice, J. Leukoc. Biol. 1987; 42: 204-212.
353. Ekert, H., Jurk, I. H., Waters, K. D., and Tiedemann, K., Prophylactic co-trimoxazole and lactobacilli preparation in neutropenic patients, Med. Pediatr. Oncol., 1980; 8: 47-51.
354. Salminen, E., Elomaa, I., Minkkinen, J., Vapaatalo, H., and Salminen, S., Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures, Clin. Radiol., 1988; 39: 435-437.
355. Elmer, G. W., Surawicz, C. M., and McFarland, L. V., Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections, J. Am. Med. Assoc., 1996; 275: 870-876.
356. Saavedra, J. M., Bauman, N. A., Oung, I., Perman, J. A., and Yolken, R. H., Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus, Lancet, 1994; 344: 1046-1049.
357. Silva, M., Jacobus, N. V., Deneke, C., and Gorbach, S. L., Antimicrobial substance from a human Lactobacillus strain, Antimicrob. Agents Chemother., 1987; 31: 1231-1233.
358. Oksanen, P. J., Salminen, S., Saxelin, M., Hämäläinen, P., Ihantola-Vormisto, A., Muurasniemi-Isoviita, L., Nikkari, S., Oksanen, T., Porste, I., Salminen, E., Siitonen, S., Stuckey, H., Toppila, A., and Vapaatol, H., Prevention of travellers' diarrhoea by Lactobacillus GG, Ann. Med., 1990; 22: 53-56.
359. Siitonen, S., Vapaatalo, H., Salminen, S., Gordin, A., Saxelin, M., Wikberg, R., and Kirkkola, A. L., Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea, Ann. Med., 1990; 22: 57-59.
360. Isolauri, E., Juntunen, M., Rautanen, T., Satakunta, P., and Koivula, T., A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children, Pediatrics, 1991; 88: 90-97.
361. Goldin, B. R., Gualteri, L., Barakat, S., Moore, R., Gorbach, S. L., and Meydani, S., The effect of Lactobacillus species (strain GG) on DMH-induced rat intestinal tumours and on human immunological function, XVII International Congress on Microbial Ecology and Disease, Helsinki, Finland, August, 1992.
362. Stansbridge, F. M., Walker, V., Hall, M. A., Smith, S. L., Millar, M. R., Bacon, C., and Chen, S., Effects of feeding premature infants with Lactobacillus GG on gut fermentation, Arch. Dis. Child., 1993; 69: 488-492.
363. Isolauri, E., Majamaa, H., Arvola, T., Rantala, I., Virtanen, E., and Arvilomm, H., Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats, Gastroenterology, 1993; 105: 1643-1650.
364. Nanji, A., Khettry, U., and Sadrazedh, M., Lactobacillus feeding reduces endotoxemia severity of experimental alcoholic liver disease, Proc. Soc. Exp. Biol. Med., 1994; 205: 243-247.
365. Isolauri, E., Kaila, M., Mykkänen, H., Ling, W. H., and Salminen, S., Oral bacteriotherapy for viral gastroenteritis, Dig. Dis. Sci., 1994; 39: 2595-2600.
366. Kaila, M., Isolauri, E., Saxelin, M., Arviliommi, H., and Vesikari, T., Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea, Arch. Dis. Child., 1995; 72: 51-53.
367. Raza, S., Graham, S. M., Allen, S. J., Sultana, S., Cuevas, L., and Hart, C. A., Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan, Pediatr. Infect. Dis. J., 1995; 14: 107-111.
368. Sheen, P., Oberhelman, R. A., Gilman, R. H., Cabrera, L., Verastegui, M., and Madico, G., Short report: a placebo-controlled study of Lactobacillus GG colonization in one-to-three-year-old Peruvian children, J. Trop. Med. Hyg., 1995; 52: 389-392.
369. Biller, J. A., Katz, A. J., Flores, A. F., Buie, T. M., and Gorbach, S. L., Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG, J. Pediatr. Gastroenterol. Nutr., 1995; 21: 224-226.
370. Goldin, B. R., Gualtieri, L. J., and Moore, R. P., The effects of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat, Nutr. Cancer, 1996; 25: 197-204.
371. Malin, M., Verronen, P., Mykkanen, H., Salminen, S., and Isolauri, E., Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora? Br. J. Rheumatol., 1996; 35: 689-694.
372. Sutas, Y., Hurme, H., and Isolauri, E., Downregulation of anti-CD3 antibody-induced IL-4 production of bovine caseins hydrolyzed with Lactobacillus GG-deri ved enzymes, Scand. J. Immunol., 1996; 43: 687-689.
373. Majamaa, H. and Isolauri, E., Probiotics: a novel approach in the management of food allergy, J. Allergy Clin. Immunol., 1997; 99: 179-185.
374. Shornikova, A. V., Isolauri, E., Burkanova, L., Lukovnikova, S., and Vesikari, T., A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea, Acta Paediatr., 1997; 86: 460-465.
375. Guarino, A., Canani, R. B., Spagnuolo, M. I., Albano, F., and Di Benedetto, L., Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea, J. Pediatr. Gastroenterol. Nutr., 1997; 25: 516-519.
376. El-Nezami, H., Kankaanpaa, P., Salminen, S., and Ahokas, J., Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin Bl, Food Chem. Toxicol., 1998; 36: 321-326.
377. Brunser, O., Araya, M., Espinoza, J., Guesry, P. R., Secretin, M. C., and Pacheco, I., Effect of an acidified milk on diarrhoea and the carrier state in infants of low socio-economic stratum, Acta Paediatr. Scand., 1989; 78: 259-264.
378. Roggero, P., Volpe, C., Ceccatelli, M. P., Lambri, A., Giuliani, M. G., Donattini, T., Garavaglia, M. C., and De Vincentiis, A., Crystalline lactulose and oral preparations of microorganisms for the treatment of chronic aspecific diarrhea in children. A controlled clinical study, Minerva Pediatr., 1990; 42: 147-150.
379. Boudraa, G., Touhami, M., Pochart, P., Soltana, R., Mary, J.-Y., and Desjeux, J.-F., Effect of feeding yogurt versus milk in children with persistent diarrhea, J. Pediatr. Gastroenterol. Nutr., 1990; 11: 509-513.
380. Touhami, M., Boudraa, G., Mary, J. Y., Soltana, R., and Desjeux, J. F., Clinical consequences of replacing milk with yogurt in persistent infantile diarrhea, Ann Pediatr. (Paris), 1992; 39: 79-86.
381. Millar, M. R., Bacon, C., Smith, S. L., Walker, V., and Hall, M. A., Enteral feeding of premature infants with Lactobacillus GG, Arch. Dis. Child., 1993; 69: 483-487.
382. Tojyo, M., Oikawa, T., Morikawa, Y., Yamashita, N., Iwata, S., Satoh, Y., Hanada, J., and Tanaka, R., The effects of Bifido-bacterium breve administration on Campylobacter enteritis, Ada Paediatr. Jpn., 1987; 29: 160-167.
383. Langhendries, J. P., Detry, J., Van Hees, J., Lamboray, J. M., Darimont, Mozin, M. J., Secretin, M. C., and Senterre, J., Effect of a fermented infant formula containing viable Bifidobacteria on the fecal flora composition and pH of healthy full-term infants, J. Pediatr. Gastroenterol. Nutr., 1995; 21: 125-129.
384. Pant, A. R., Graham, S. M., Allen, S. J., Harikul, S., Sabchareon, A., Cuevas, L., and Hart, C. A., Lactobacillus GG and acute diarrhoea in young children in the tropics, J. Trop. Pediatr., 1996; 42: 162-165.
385. Pozo-Olano, J., Warram, J. H. J., Gomez, R. G., and Cavazos, M. G., Effect of a lactobacilli preparation of traveler's diarrhea. A randomized, double-blind clinical trial, Gastroenterology, 1978; 74: 829-830.
386. Gotz, V., Romankiewicz, J. A., Moss, J., and Murray, H. W., Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation, Am. J. Hosp. Pharm., 1979; 36: 754-757.
387. Contardi, I., Oral bacterial therapy in prevention of antibiotic-induced diarrhea in childhood, Le Clin. Ter., 1991; 136: 409-413.
388. Honig, P. J., Diaper dermatitis. Factors to consider in diagnosis and treatment, Postgrad. Med., 1983; 74: 79-84.
389. Weston, W. L., Lane, A. T., and Weston, J. A., Diaper dermatitis: current concepts, Pediatrics, 1980; 66: 532-536.
390. Kocian, J., Irritable bowel syndrome, Vnitr Lek, 1994; 40: 246-249.
391. Henriksson, R., Franze, L., Sandstrom, K., Nordin, A., Arevarn, M., and Grahn, E., Effects of active addition of bacterial cultures in fermented milk to patients with chronic bowel discomfort following irradiation, Support Care Cancer, 1995; 3: 81-83.
392. Loguercio, C., Del Vecchio Blanco, C., and Coltorti, M., Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encepholopathy: a controlled study, J. Int. Med. Res., 1987; 15: 335-343.
393. Tamime, A. Y., Marshall, V. M. E., and Robinson, R. K., Microbiological and technical aspects of milks fermented by bifido-bacteria, J. Dairy Res., 1995; 62: 151-187.
394. Hull, R. R., Conway, P. L., and Evans, A. J., Probiotic foods - a new opportunity, Food Australia, 1992; 44: 112-113.
395. Borgstrom, G., Principles of Food Science, in Food microbiology and biochemistry, Vol. 2, Macmillan, New York, 1968, 103-126.
396. Oberman, H., Fermented milks, in Microbiology of Fermented Foods, Vol. 1, Wood, B. J. B., Ed., Elsevier Applied Sciences, London, 1985, 167-195.
397. Campbell-Platt, G., Fermented foods - a world perspective, Food Res. Int., 1994; 27: 253-257.
398. Hammes, W. P. and Tichaczek, P. S., The potential of lactic acid bacteria for the production of safe and wholesome food, Z. Lebensm. Unters. Forsch., 1994; 198: 193-201.
399. Modler, H. W., McKellar, R. C., and Yaguchi, M., Bifidobacteria and bifidogenic factors, Can. Inst. Food Sci. Techol., 1990a; 23: 29-41.
400. Hughes, D. B. and Hoover, D. G., Bifidobacteria: their potential for use in American diary products, Food Technol., 1991; April: 74-83.
401. Ishibashi, N. and Shimamura, S., Bifido-bacteria: research and development in Japan, Food Technol., 1993; June: 126-135.
402. Kurmann, J. A., Rasic, J. L., and Kroger, M., Encyclopedia of fermented fresh milk products, Van Nostrand Reinhold, New York, 1992.
403. Lee, Y. K. and Wong, S. F., Lactic acid bacteria, Salminen, S. and von Wright, A., Eds., Marcel Dekker, 1993, 97-109.
404. Klaenhammer, T. R. and Kleeman, E. G., Growth characteristics, bile sensitivity, and freeze damage in colonial variants of Lactobacillus acidophilus, Appl. Environ. Microbiol., 1981; 41: 1461-1467.
405. Gasson, M. J. and Fitzgerald, G. F., Gene transfer systems and transposition. In: Genetics and biotechnology of lactic acid bacteria, Gasson, M. and de Vos, W. M., Eds., Blackie Academic & Professional, New York, 1994, 1-44.
406. Mercenier, A., Pouwels, P. H., and Chassy, B. M., Genetic engineering of lactobacilli, leuconostocs and Streptococcus thermophilus. In: Genetics and biotechnology of lactic acid bacteria, Gasson, M. J. and DeVos, W. M., Eds., Blackie Academic & Professional, New York, 1994, 253-293.
407. Klein, G., Bonaparte, C., and Reuter, G., Laktobazillen als Starterkulturen für die Milchwirtschaft unter den Gesichtpunkt der Sicherer Biotechnologie. Milchwissenschaft 1992; 47: 632-636.
408. Aguirre, M. and Collins, M. D., Lactic acid bacteria and human clinical infection, J. Appl. Bacteriol., 1993; 75: 97-107.
409. Gasser, F., Safety of lactic acid bacteria and their occurrence in human clinical infections, Bull. Inst. Pasteur, 1994; 92: 45-67.
410. Adams, M. R. and Marteau, P., On the Safety of lactic acid bacteria from food, Int. J. Food Microbiol., 1995; 27: 263-264.
411. Marschall, F., Der Doderleinsche Bacillus vaginalis als endocarditiserreger, Zentralbl. Bakt. I. Abteilung Originale, 1938; 141: 153-159.
412. Griffiths, J. K., DaIy, J. S., and Dodge, R. A., Two casees of endocarditis due to Lactobacillus sp.: antimicrobial susceptibility, review and discussion of therapy, Clin. Infect. Dis., 1992; 15: 250-255.
413. Mitsuoka, T., Bifidobacteria and their role in human health, J. Indust. Micro., 1990; 6: 263-268.
414. Sanders, M., Development of consumer probiotics for the U.S. market, Br. J. Nutr., 1998; 80: S213-S218.
415. Beck, C. and Necheles, H., Beneficial effects of administration of Lactobacillus acidophilus (sic) in diarrheal and other intestinal disorders, Am. J. Gastroenterol., 1961; 35: 522-530.
416. Niv, M., Levy, W., and Greenstein, N. M., Yogurt in the treatment of infantile diarrhea, Clin. Pediatr., 1963; 7: 407-411.
417. Rapoport, L. and Levine, W. I., Treatment of oral ulcertaion with lactobacillus tablets. Report of 40 cases, Oral Surg. Oral Med. Oral Pathol., 1965; 20: 591-593.
418. Schneegans, E., Haarscher, A., Lutz, A., Lévy-Silagy, J., and Schmittbuhl, J., Contribution a l'étude de Bifidibacterium-bifidum. Essais d'implantation chez le nourrisson sain et chez le porteur d'Escherichia cou pathogènes, Ann. de Pédiatrie, 1966; Juin/Juillet, 457-462.
419. Muting, D., Eschrich, W., and Mayer, J. B., The effect of Bifidobacterium bifldum on intestinal bacterial flora and toxic protein metabolites in chronic liver disease, Am. J. Proctol., 1968; 19: 336-342.
420. Gertenrich, R. L. and Hart, R. W., Treatment of oral ulcerations with Bacid (Lactobacillus acidophilus), Oral Surg. Med. Oral Pathol., 1970; 30: 192-200.
421. Pearce, J. L. and Hamilton, J. R., Controlled trial of orally administered lactobacilli in acute infantile diarrhea, J. Pediatr., 1974; 84: 261-262.
422. Mann, G. V., Studies of a surfactant and cholesteremia in the Maasai, Am. J. Clin. Nutr., 1974; 27: 464-469.
423. Vazquez, L. F. M. and Rivera, H. M., Clinical evaluation of lactovagil, Prensa Med. Mex., 1976; 41: 428-431.
424. Hensgens, C. and Klasterski, J., Intestinal colonization with lactobacilli strains in neutropenic patients, Biomedicine, 1976; 25: 11-15.
425. Pozo-Olano, J. D., Warram, Jr., J. G., Gomez, R. G., Jr., and Cavazos, M. G., Effect of a Lactobacilli preparation on traveler's diarrhea: A randomized, double blind clinical trial, Gastroenterology, 1978; 74: 829-830.
426. Hepner, G., Fried, R., St. Joer, S., Fusetti, L., and Morin, R., Hypocholesterolemic effect of yogurt and milk, Am. J. Clin. Nutr., 1979; 32: 19-24.
427. Sharma, J. K., Kapoor, K. K., and Mukhija, R. D., Clinical trial of Sporlac in the treatment of recurrent aphthous ulceration, Uttar Pradesh State Dent. J., 1980; 11: 7-12.
428. Satta, A., Delplano, A., Cossu, P., and Cossellu, S., Treatment of enterocolitis and other intestianl disorders with a Bifido-bacterium bifidum and Lactobacillus acidophilus combination, Clin. Ter., 1980; 94: 173-184.
429. Bellomo, G., Mangiagle, A., Nicastro, L., and Frigerio, G., A controlled double-blind study of SF68 strain as a new biological preparation for the treatment of diarrhea in pediatarics, Curr. Ther. Res., 1980; 28: 927-936.
430. Rossouw, J. E., Burger, E. M., van der Vyver, P., and Ferreira, J. J., The effect of skim milk, yogurt, and full cream milk on human serum lipids, Am. J. Clin. Nutr., 1981; 34: 351-356.
431. Bruno, F. and Grigerio, G., Eine Neuartige Möglichkeit zur Behandlung der Enteritis -Kontrollierte Doppelblindversuche mit dem Stamm SF 68, Schweiz Rundschau Med., 1981; 70: 1717-1720.
432. Robins-Browne, R. M. and Levine, M. M., The fate of ingested lactobacilli in the proximal small intestine, Am. J. Clin. Nutr., 1981; 34: 514-519.
433. Thompson, L. U., Jenkins, D. J. A., Vicamer, M. A., Reichert, R., Jenkins, A., and Kamulsky, J., The effect of fermented and unfermented milks on serum cholesterol, Am. J. Clin. Nutr., 1982; 36: 1106-1111.
434. Bogdanov, I., Observation on the therapeutic effect of the anti-cancer preparation from Lactobacillus bulgaricus 'LB-51' tested on 100 oncologic patients, Sofia Book Press, 1982, 127.
435. Kim, H. S. and Gilliland, S. E., Lactobacillus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans, J. Diary Sci., 1983; 66: 959-966.
436. Clements, M. L., Levine, M. M., Ristaino, P. A., Daya, V. E., and Hughes, T. P., Exogenous lactobacilli fed to man-their fate and ability to prevent diarrheal disease, Prog. Food Nutr. Sci., 1983; 7: 29-37.
437. Tanaka, R., Takayama, H., Morotomi, M., Kuroshima, T., Ueyama, S., Matsumoto, K., Kuroda, A., and Mutai, M., Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora, Bifidobacteria Microflora, 1983; 2: 17-24.
438. Bazzarre, T. L., Liu-Wu, S., and Yuhas, J. A., Total and HDL-cholesterol concentrations: yogurt and calcium supplementation, Nutr. Rep. Int., 1983; 28: 1225-1232.
439. Newcomer, A. D., Park, H. S., O'Brien, P. C., and McGill, D. B., Response of patients with irritable bowel syndrome and lactase deficiency using unfermented acidophilus milk, Am. J. Clin. Nutr., 1983; 38: 257-263.
440. Jaspers, D. A., Massey, L. K., and Luedecki, L. O., Effect of consuming yogurts prepared with 3 culture strains on human serum lipoproteins, J. Food Sci., 1984; 49: 1178-1181.
441. Savaiano, D. A., AbauElanor, A., Smith, D. E., and Levitt, M. D., Lactose malabsorption from yogurt, pasteurized yogurt, sweet acidophilus milk, and cultured milk in lactase-deficient individuals, Am. J. Clin. Nutr., 1984; 40: 1219-1223.
442. Goldin, B. R. and Gorbach, S. L., The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity, Am. J. Clin. Nutr., 1984; 39: 756-761.
443. Reuman, P. D., Duckworth, D. H., Smith, K. L., Kagan, R., Bucciarelli, R. L., and Ayour, E. M., Lack of effect of Lactobacillus on gastrointestinal bacterial colonization in premature infants, Pediatr. Infect. Dis., 1986; 5: 663-668.
444. Prajapati, J. B., Shah, R. K., and Dave, J. M., Nutritional and therapeutic benefits of a blended-spray dried acidophilus preparation, Cultured Dairy Prod. J., 1986; May: 16-21.
445. Hotta, M., Sato, Y., Iwata, S., Yamashita, N., Sunakawa, K., Oikawa, T., Tanaka, R., Wantanabe, K., Takayama, H., Yajima, M., Sekiguchi, S., Arai, S., Sakurai, T., and Mutai, M., Clinical effects of Bifidobacterium preparations on pediatric intractable diarrhea, Keio J. Med., 1987; 36: 298-314.
446. Singh, T., Yougurt feeding during acute diarrhea (Letter to the Editor), J. Ind. Acad. Pediatr., 1987; 24: 530.
447. Dewit, O., Boudraa, G., Touhami, M., and Desjeux, J. F., Breath hydrogen test and stools characteristics after the ingestion of milk and yogurt in malnourished children with chronic diarrhea and lactase deficiency, J. Trop. Pediatr., 1987; 33: 177-180.
448. Gorbach, S. L., Chang, T.-W., and Goldin, B. R., Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG, Lancet, 1987; 330: 1519.
449. Colombel, J. F., Cortot, A., Neut, C., and Romond, C., Yogurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects, Lancet, 1987; 330: 43.
450. McDonough, F. E., Wong, N. P., Hitchins, A., and Bodwell, C. E., Alleviation of lactose malabsorption from sweet acidophilus milk, Am. J. Clin. Nutr., 1987; 42: 345-346.
451. Wytock, D. H., and DiPalma, J. A., All yogurts are not created equal, Am. J. Clin. Nutr., 1988; 47: 454-457.
452. Black, F. T., Anderson, P. L., Ørskov, J., Ørskov, F., Gaarslev, K., and Laulund, S., Prophylactic efficacy of Lactobacilli on traveler's diarrhea, Travel Med., 1989; Suppl: 333-335.
453. Wunderlich, P. F., Braun, L., Fumagalli, I., Apuzzo, V. D., Heim, F., Karly, M., Lodi, R., Poplitta, G., Vonbank, F., and Zeitner, L., Double-blind report on the efficacy of lactic acid-producing Enerococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea, J. Int. Med. Res., 1989; 17: 333-338.
454. Mitra, A. K. and Rabbani, G. H., A double-blind, controlled trial of bioflorin (Streptococcus faecium SF68) in adults with acute diarrhea due to Vibrio cholerae and enterotoxigenic Escherichia coli, Gastroenterology, 1990; 99: 1149-1152.
455. Beau, J. P., Fontaine, O., and Garenne, M., Management of malnourished children with acute diarrhea and sugar intolerance, J. Trop. Pediatr., 1990; 36: 86-89.
456. Bayona-Gonzalez, A., Lopez-Camara, V., and Gomez-Castellanos, A., Final results of a dental caries clinical trial using heat killed lactic bacteria (Streptococci and Lactobacilli) orally, Pract. Odontol., 1990; 11: 41-47.
457. Tankanow, R. M., Ross, M. B., Ertel, I. J., Dickinson, D. G., McCormick, L. S., and Garfinkel, J. F., A double-blind, placebo-controlled study of the efficacy of lactinex in the prophylaxis of amoixillin-induced diarrhea, DICP Ann. Pharmacother., 1990; 24: 382-384.
458. Berrada, N., LeMelano, J., LaRoche, G., Thollvenot, P., andPiaia, M., Bifidobacterium from fermented milks: survival during gastric transit, J. Dairy Sci., 1991; 74: 409-413.
459. Tomoda, T., Nakano, Y., and Kageyama, T., Effect of yogurt and yogurt supplemented with Bifidobacterium and/or lactulose in healthy persons: a comparative study, Bifidobacteria Microflora, 1991; 10: 123-130.
460. Black, F. T., Einarsson, K., Lidbeck, A., Orrhage, K., and Nord, C. E., Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment, Scand. J. Infect. Dis., 1991; 23: 247-254.
461. Halpern, G. M., Vruwink, K. G., Van de Water, J., Keen, C. L., and Gershwin, M. E., Influence of long-term yoghurt consumption in young adults, Int. J. Immunother., 1991; 7: 205-210.
462. Martini, M. C., Lerebours, E. C., Lin, W.-J., Harlander, S. K., Berrada, N. M., Antoine, J. M., and Savaiano, D. A., Strains and species of lactic acid bacteria in fermented milks (yogurts): effect on in vivo lactose digestion, Am. J. Clin. Nutr., 1991b; 54: 1041-1046.
463. Bennet, R., Nord, C. E., and Zetterström, R., Transient colonization of the gut of newborn infants by orally administered bifidobacteria and lactobacilli, Acta Paediatr., 1992; 81: 784-787.
464. Benno, Y. and Mitsuoka, T., Impact of Bifidobacterium longum on human fecal microflora, Microbiol. Immunol., 1992; 36: 683-694.
465. Ellegaard, J., Peterslund, N. A., and Black, F. T., Infection prophylaxis in neutropenic patients by joral administration of Lactobacilli, Presentation, Seventh International Symposium on Infections in the Immunocompromised Host, Boulder, CO, June 21-24, 1992.
466. Balli, F., Bertolani, P., Giberti, G., and Amarri, S., High-dose oral bacteria-therapy for chronic non-specific diarrhea of infancy, Pedlatr. Med. Chir., 1992; 14: 13-15.
467. Hilton, E., Isenberg, H. D., Alperstein, P., France, K., and Borenstein, M. T., Ingestion of yogurt containing Lactobacillus acidophllus as prophylaxis for Candidal vaginitis, Ann. Intern. Med., 1992; 116: 353-357.
468. Trapp, C. L., Chang, C. C., Halpern, G. M., Keen, C. L., and Gershwin, M. E., The influence of chronic yogurt consumption on populations of young and elderly adults, Int. J. Immunother., 1993; 9: 53-64.
469. Saxelin, M., Ahokas, M., and Salminen, S., Dose response on the fecal colonization of Lactobacillus strain GG administered two different formulations, Microb. Ecol. Hlth. Dis., 1993; 6: 119-122.
470. Mahe, S., Marteau, P., Huneau, J. F., Thuillier, F., and Tome, D., Intestinal nitrogen and electrolyte movements following fermented milk ingestion in man, Br. J. Nutr., 1994; 71: 169-180.
471. Bhutta, Z. A., Molla, A. M., Issani, Z., Badruddin, S., Hendricks, K., and Snyder, J. D., J. Pediatr. Gastroenterol. Nutr., 1994; 18: 45-52.
472. Baerheim, A., Larsen, E., and Digranes, A., Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women, Scand. J. Prim. Hlth. Care, 1994; 12: 239-243.
473. Pedrosa, M. C., Golner, B. B., Goldin, B. R., Barakat, S., Dallal, G. E., and Russell, R. M., Survival of yogurt-containing organisms and Lactobacillus gasseri (ADH) and their effect on bacterial enzyme activity in the gastrointestinal tract of healthy and hypochlorhydric elderly subjects. Am. J. Clin. Nutr., 1995; 61: 353-359.
474. Katelaris, P. H., Salam, I., and Farthing, M. J. G., Lactobacilli to prevent traveler's diarrhea? N. Engl. J. Med., 1995; 333(20): 1360-1361.
475. Montes, R. G., Bayless, T. M., Saavedra, J. M., and Perman, J. A., Effect of milks inoculated with Lactobacillus acidophilus or a yogurt starter culture in lactose-maldigesting children, J. Dairy Sci., 1995; 78: 1657-1664.
476. Gaon, D., Doweck, Y., Zavaglia, A. G., Holgado, A. R., and Oliver, G., Digestion de la lactosa por una leche fermentada con Lactobacillus acidophilus y Lactobacillus caseide origen humano, Medicina (Buenos Aires), 1995; 55: 237-242.
477. Saxelin, M., Pessi, T., and Salminen, S., Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers, Int. J. Food Micobiol., 1995; 25: 199-203.
478. Kok, R. G., de Waal, A., Schut, F., Welling, G. W., Weenk, G., and Hellingwerf, K. J., Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces, Appl. Environ. Microbiol., 1996; 62: 3668-3672.
479. Bennett, R. G., Gorbach, S. L., Goldin, B. R., Chang, T.-W., Laughon, B. E., Greenuough, W. B., and Bartlett, J. G., Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG, Nutr. Today, (Suppl.) 1996; 31: 35S-42S.
480. Michielutti, F., Bertini, M., Presciuttini, B., and Andreotti, G., Clinical assessment of a new oral bacterial treatment for children with acute diarrhea, Minerva Med., 1996; 87(11): 545-550.
481. Parent, D., Bossens, M., Bayot, D., Kirkpatrick, C., Graf, F., Wilkerson, F. E., and Kaiser, R. R., Therapy of bacterial vaginosis using exogenously applied Lactobacilli acidophilius and a low dose of estriol: a placebeo-controlled multicenter clinical trial, Arzneimittelforschung Drug Res., 1996; 46: 68-73.
482. Guerin-Danan, C., Chabanet, C., Pedone, C., Popot, F., Vaissade, P., Bouley, C., Szylit, O., and Andrieux, C., Milk fermented with yogurt cultures and Lactobacillus casei compared with yogurt and gelled milk: influence on intestinal microflora in healthy infants, Am. J Clin Nutr., 1997; 67: 111-117.
483. Ribeiro, H., Jr. and Vanderhoof, J. A., Reduction of diarrheal illness following administration of Lactobacillus plantarum 299V in a day care facility, Abstract #P162, 5th Joint Meeting of ESPGHAN & NASPGN, Toulouse, France, May 27-30, 1998.
484. Loret de Mola, O., Gonzalez-Vallina, R., Muinos, W., Reeves-Garcia, J., and Acosta, J., Recovery of chronic Clostridium difficile colitis with the use of Lactobacillus GG, Abstract #P163, 5th Joint Meeting of ESPGHAN & NASPGN, Toulouse, France, May 27-30, 1998.
485. Di Benedetto, L., Raia, V., Pastore, A., Albano, F., Spagnuolo, M. I., De Vizia, and Guarino, A., Lactobacillus casei strain GG as adjunctive treatment to children with cystic fibrosis, Abstract #P164, 5th Joint Meeting of ESPGHAN & NASPGN, Toulouse, France, May 27-30, 1998.
486. Chouraqui, J. P., van Egroo, and Fichot, M. C., Prevention of diarrhea by feeding infants with an acidified milk formula containing Bifidobacterium bifidum (Bb), Abstract #P165, 5th Joint Meeting of ESPGHAN & NASPGN, Toulouse, France, May 27-30, 1998.
487. Guandalini, S., ESPGHAN, and working group on acute diarrhea, Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial, Abstract #O19, 5th Joint Meeting of ESPGHAN & NASPGN, Toulouse, France, May 27-30, 1998.
488. Dong, M.-Y., Chang, T.-W., and Gorbach, S. L., Effects of feeding Lactobacillus GG on lethal irradiation in mice, Diagn. Microbiol. Infect. Dis., 1987; 7: 1-7.
489. Donohue, D. C. and Salminen, S., Safety of probiotic bacteria, Asia Pacific J. Clin. Nutr., 1996; 5: 25-28.
490. Clock, O. R., One hundred seventeen cases of infant diarrhea, J. Am. Med. Assoc., 1913; 61: 164-168.